Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14681 

Congressional Review Act 

The Congressional Review Act, 5 

U.S.C. 801 et seq., as added by the Small 

Business Regulatory Enforcement 

Fairness Act of 1996, generally provides 

that before a rule may take effect, the 

agency promulgating the rule must 

submit a rule report, which includes a 

copy of the rule, to each House of the 

Congress and to the Comptroller General 

of the United States. EPA will submit a 

report containing this rule and other 

required information to the U.S. Senate, 

the U.S. House of Representatives, and 

the Comptroller General of the United 

States prior to publication of the rule in 

the Federal Register. A major rule 

cannot take effect until 60 days after it 

is published in the Federal Register. 

This action is not a ‘‘major rule’’ as 

defined by 5 U.S.C. section 804(2). 

Under section 307(b)(1) of the Clean 

Air Act, petitions for judicial review of 

this action must be filed in the United 

States Court of Appeals for the 

appropriate circuit by May 29, 2007. 

Filing a petition for reconsideration by 

the Administrator of this final rule does 

not affect the finality of this rule for the 

purposes of judicial review nor does it 

extend the time within which a petition 

for judicial review may be filed, and 

shall not postpone the effectiveness of 

such rule or action. This action may not 

be challenged later in proceedings to 

enforce its requirements. (See section 

307(b)(2).) 

List of Subjects in 40 CFR Part 52 

Environmental protection, Air 

pollution control, Nitrogen dioxide, 

Ozone, Reporting and recordkeeping 

requirements, and Volatile organic 

compounds. 

Dated: February 27, 2007. 

Steve Rothblatt, 

Acting Regional Administrator, Region 5. 

■ For the reasons stated in the preamble, 

part 52, chapter I, of title 40 of the Code 

of Federal Regulations is amended as 

follows: 

PART 52—[AMENDED] 

■ 1. The authority citation for part 52 

continues to read as follows: 

Authority: 42 U.S.C. 7401 et seq. 

Subpart P—Indiana 

■ 2. Section 52.770 is amended by 

removing and reserving paragraphs 

(c)(91) and (c)(166), and adding 

paragraph (c)(178) to read as follows: 

§ 52.770 Identification of plan. 

* * * * * 

(c) * * * 

(178) On August 25, 2006, Indiana 

submitted final adopted revisions to its 

emission reporting requirement rules as 

a revision to the Indiana State 

Implementation Plan. 

(i) Incorporation by reference. Indiana 

Administrative Code Title 326: Air 

Pollution Control Board, Article 2: 

Permit Review Rules, Rule 6 Emission 

Reporting, Section 1: Applicability, 

Section 3: Compliance schedule, and 

Section 4: Requirements. Approved by 

the Attorney General June 29, 2006. 

Approved by the Governor July 13, 

2006. Filed with the Publisher July 14, 

2006. Published on the Indiana Register 

Web site August 9, 2006, Document 

Identification Number (DIN):20060809–

IR–326050078FRA. Effective August 13, 

2006. 

[FR Doc. E7–5655 Filed 3–28–07; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 80 

[FRL–8293–1] 

Regulation of Fuels and Fuel 

Additives: Extension of the 

Reformulated Gasoline Program to the 

East St. Louis, IL Ozone Nonattainment 

Area 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Withdrawal of direct final rule. 

SUMMARY: EPA published a direct final 

rule on December 27, 2006, to extend 

the reformulated gasoline program to 

the Illinois portion of the St. Louis 

Illinois-Missouri ozone nonattainment 

area effective as of May 1, 2007. 

However, we received an adverse 

comment during the 30 day comment 

period and are now withdrawing that 

direct final rule. 

DATES: As of March 29, 2007, EPA 

withdraws the direct final rule 

published at 71 FR 77615, on December 

27, 2006. 

FOR FURTHER INFORMATION CONTACT: Kurt 

Gustafson at (202) 343–9219. 

SUPPLEMENTARY INFORMATION: Because 

EPA received adverse comment, we are 

withdrawing the direct final rule for 

‘‘Regulation of Fuels and Fuel 

Additives: Extension of the 

Reformulated Gasoline Program to the 

East St. Louis, Illinois Ozone 

Nonattainment Area.’’ We published the 

direct final rule on December 27, 2006 

(71 FR 77615), that would have 

approved the State of Illinois’s request 

to opt-in to the Federal Reformulated 

Gasoline Program effective as of May 1, 

2007. That action would have amended 

our regulations to make the Illinois 

portion of the St. Louis, IllinoisMissouri ozone nonattainment area a 

covered area and prohibit the sale of 

conventional gasoline. We stated in that 

Federal Register document that if we 

received adverse comment by January 

26, 2007, we would publish a timely 

notice of withdrawal in the Federal 

Register. We subsequently received an 

adverse comment. 

We will address the comment in a 

subsequent final action based on the 

parallel proposal also published on 

December 27, 2006 (71 FR 77690). As 

stated in the parallel proposal, we will 

not institute a second comment period 

on this action. 

Dated: March 22, 2007. 

Stephen L. Johnson, 

Administrator. 

PART 80—REGULATION OF FUELS 

AND FUEL ADDITIVES 

§ 80.70 [Amended]. 

■ Accordingly, the amendment to 40 

CFR 80.70 which was published in the 

Federal Register on December 27, 2006 

(71 FR 77615) is withdrawn as of March 

29, 2007. 

[FR Doc. E7–5808 Filed 3–28–07; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

40 CFR Part 721 

[EPA–HQ–OPPT–2003–0063; FRL–7699–5] 

RIN 2070–AB27 

Significant New Use Rules on Certain 

Chemical Substances and Notification 

on Certain Substances for Which 

Significant New Use Rules are Not 

Being Issued 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Direct final rule. 

SUMMARY: EPA is promulgating 

significant new use rules (SNURs) under 

section 5(a)(2) of the Toxic Substances 

Control Act (TSCA) for 65 chemical 

substances which were the subject of 

premanufacture notices (PMNs). 

Thirteen of these chemical substances 

are subject to TSCA section 5(e) consent 

orders issued by EPA. This action 

requires persons who intend to 

manufacture, import, or process any of 

these 65 chemical substances for an 

activity that is designated as a 

significant new use by this rule to notify 


cprice-sewell on PROD1PC61 with RULES
14682 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

EPA at least 90 days before commencing 

that activity. The required notification 

will provide EPA with the opportunity 

to evaluate the intended use and, if 

necessary, to prohibit or limit that 

activity before it occurs. This direct 

final rule also provides notification on 

two substances for which EPA has 

decided not to issue significant new use 

rules at this time. 

DATES: The effective date of this rule is 

May 29, 2007 without further notice, 

unless EPA receives adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments before 

April 30, 2007. This rule shall be 

promulgated for purposes of judicial 

review at 1 p.m. (e.s.t.) on April 12, 

2007. 

If EPA receives adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, on one or 

more of these SNURs before April 30, 

2007, EPA will withdraw the relevant 

sections of this direct final rule before 

its effective date. EPA will then issue a 

proposed SNUR for the chemical 

substance(s) on which adverse or 

critical comments were received, 

providing a 30-day period for public 

comment. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2003–0063, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the on-line 

instructions for submitting comments. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460–

0001. 

• Hand Delivery: OPPT Document 

Control Office (DCO), EPA East Bldg., 

Rm. 6428, 1201 Constitution Ave., NW., 

Washington, DC. Attention: Docket ID 

number EPA–HQ–OPPT–2003–0063. 

The DCO is open from 8 a.m. to 4 p.m., 

Monday through Friday, excluding legal 

holidays. The telephone number for the 

DCO is (202) 564–8930. Such deliveries 

are only accepted during the DCO’s 

normal hours of operation, and special 

arrangements should be made for 

deliveries of boxed information. 

Instructions: Direct your comments to 

docket ID number EPA–HQ–OPPT–

2003–0063. EPA’s policy is that all 

comments received will be included in 

the public docket without change and 

may be made available on-line at http:// 

www.regulations.gov, including any 

personal information provided, unless 

the comment includes information 

claimed to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Do not submit information that you 

consider to be CBI or otherwise 

protected through regulations.gov or email. The regulations.gov website is an 

‘‘anonymous access’’ system, which 

means EPA will not know your identity 

or contact information unless you 

provide it in the body of your comment. 

If you send an e-mail comment directly 

to EPA without going through 

regulations.gov, your e-mail address 

will be automatically captured and 

included as part of the comment that is 

placed in the public docket and made 

available on the Internet. If you submit 

an electronic comment, EPA 

recommends that you include your 

name and other contact information in 

the body of your comment and with any 

disk or CD ROM you submit. If EPA 

cannot read your comment due to 

technical difficulties and cannot contact 

you for clarification, EPA may not be 

able to consider your comment. 

Electronic files should avoid the use of 

special characters, any form of 

encryption, and be free of any defects or 

viruses. For additional information 

about EPA’s public docket visit the EPA 

Docket Center homepage at http:// 

www.epa.gov/epahome/dockets.htm. 

Docket: All documents in the docket 

are listed in the docket’s index available 

at http://www.regulations.gov. Although 

listed in the index, some information is 

not publicly available, e.g., CBI or other 

information whose disclosure is 

restricted by statute. Certain other 

material, such as copyrighted material, 

will be publicly available only in hard 

copy. Publicly available docket 

materials are available electronically at 

http://www.regulations.gov, or, if only 

available in hard copy, at the OPPT 

Docket. The OPPT Docket is located in 

the EPA Docket Center (EPA/DC) at Rm. 

3334, EPA West Bldg., 1301 

Constitution Ave., NW., Washington, 

DC. The EPA/DC Public Reading Room 

hours of operation are 8:30 a.m. to 4:30 

p.m., Monday through Friday, excluding 

Federal holidays. The telephone number 

of the EPA/DC Public Reading Room is 

(202) 566–1744, and the telephone 

number for the OPPT Docket is (202) 

566–0280. Docket visitors are required 

to show photographic identification, 

pass through a metal detector, and sign 

the EPA visitor log. All visitor bags are 

processed through an X-ray machine 

and subject to search. Visitors will be 

provided an EPA/DC badge that must be 

visible at all times in the building and 

returned upon departure. 

FOR FURTHER INFORMATION CONTACT: For 

general information contact: Colby 

Lintner, Regulatory Coordinator, 

Environmental Assistance Division 

(7408M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; telephone 

number: (202) 554–1404; e-mail address: 

TSCA-Hotline@epa.gov. 

For technical information contact: 

Karen Chu, Chemical Control Division 

(7405M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; telephone 

number: (202) 564–8773; e-mail address: 

chu.karen@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this Action Apply to Me? 

You may be potentially affected by 

this action if you manufacture, import, 

process, or use the chemical substances 

contained in this rule. Potentially 

affected entities may include, but are 

not limited to: 

• Manufacturers, importers, or 

processors of one or more subject 

chemical substances (NAICS codes 325 

and 324110), e.g., Chemical 

manufacturing and petroleum refineries. 

This listing is not intended to be 

exhaustive, but rather provides a guide 

for readers regarding entities likely to be 

affected by this action. Other types of 

entities not listed in this unit could also 

be affected. The North American 

Industrial Classification System 

(NAICS) codes have been provided to 

assist you and others in determining 

whether this action might apply to 

certain entities. To determine whether 

you or your business may be affected by 

this action, you should carefully 

examine the applicability provisions in 

40 CFR 721.5. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the 

technical person listed under FOR

FURTHER INFORMATION CONTACT. 

This action may also affect certain 

entities through pre-existing import 

certification and export notification 

rules under TSCA. Persons who import 

any chemical substance governed by a 

final SNUR are subject to the TSCA 

section 13 (15 U.S.C. 2612) import 

certification requirements and the 

corresponding regulations at 19 CFR 

12.118 through 12.127 and 19 CFR 

127.28. Those persons must certify that 

the shipment of the chemical substance 

complies with all applicable rules and 

orders under TSCA, including any 

SNUR requirements. The EPA policy in 

support of import certification appears 

at 40 CFR part 707, subpart B. In 

addition, any persons who export or 

intend to export a chemical substance 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14683 

that is the subject of this rule on or after 

April 30, 2007 are subject to the export 

notification provisions of TSCA section 

12(b) (15 U.S.C. 2611(b)) (see 40 CFR 

721.20), and must comply with the 

export notification requirements in 40 

CFR part 707, subpart D. 

B. What Should I Consider as I Prepare 

My Comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or e-mail. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD ROM that 

you mail to EPA, mark the outside of the 

disk or CD ROM as CBI and then 

identify electronically within the disk or 

CD ROM the specific information that is 

claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When submitting comments, remember 

to: 

i. Identify the document by docket ID 

number and other identifying 

information (subject heading, Federal 

Register date, and page number). 

ii. Follow directions. The Agency may 

ask you to respond to specific questions 

or organize comments by referencing a 

Code of Federal Regulations (CFR) part 

or section number. 

iii. Explain why you agree or disagree; 

suggest alternatives and substitute 

language for your requested changes. 

iv. Describe any assumptions and 

provide any technical information and/ 

or data that you used. 

v. If you estimate potential costs or 

burdens, explain how you arrived at 

your estimate in sufficient detail to 

allow for it to be reproduced. 

vi. Provide specific examples to 

illustrate your concerns and suggest 

alternatives. 

vii. Explain your views as clearly as 

possible, avoiding the use of profanity 

or personal threats. 

viii. Make sure to submit your 

comments by the comment period 

deadline identified. 

II. Background 

A. What Action is the Agency Taking? 

EPA is promulgating these SNURs 

using direct final procedures. These 

SNURs will require persons to notify 

EPA at least 90 days before commencing 

the manufacture, import, or processing 

of a chemical substance for any activity 

designated by these SNURs as a 

significant new use. Additional 

rationale and background to this rule are 

more fully set out in the preamble to 

EPA’s first direct final SNUR published 

in the Federal Register of April 24, 1990 

(55 FR 17376). Consult that preamble for 

further information on the objectives, 

rationale, and procedures for SNURs 

and on the basis for significant new use 

designations, including provisions for 

developing test data. 

B. What is the Agency’s Authority for 

Taking this Action? 

Section 5(a)(2) of TSCA (15 U.S.C. 

2604(a)(2)) authorizes EPA to determine 

that a use of a chemical substance is a 

‘‘significant new use.’’ EPA must make 

this determination by rule after 

considering all relevant factors, 

including those listed in TSCA section 

5(a)(2). Once EPA determines that a use 

of a chemical substance is a significant 

new use, TSCA section 5(a)(1)(B) 

requires persons to submit a significant 

new use notice (SNUN) to EPA at least 

90 days before they manufacture, 

import, or process the chemical 

substance for that use. The mechanism 

for reporting under this requirement is 

established under 40 CFR part 721.5. 

C. Applicability of General Provisions 

General provisions for SNURs appear 

under 40 CFR part 721, subpart A. 

These provisions describe persons 

subject to the rule, recordkeeping 

requirements, exemptions to reporting 

requirements, and applicability of the 

rule to uses occurring before the 

effective date of the final rule. 

Provisions relating to user fees appear at 

40 CFR part 700. According to 40 CFR 

721.1(c), persons subject to these SNURs 

must comply with the same notice 

requirements and EPA regulatory 

procedures as submitters of PMNs under 

TSCA section 5(a)(1)(A). In particular, 

these requirements include the 

information submission requirements of 

TSCA section 5(b) and 5(d)(1), the 

exemptions authorized by TSCA section 

5 (h)(1), (h)(2), (h)(3), and (h)(5), and the 

regulations at 40 CFR part 720. Once 

EPA receives a SNUN, EPA may take 

regulatory action under TSCA section 

5(e), 5(f), 6, or 7 to control the activities 

on which it has received the SNUN. If 

EPA does not take action, the Agency is 

required under TSCA section 5(g) to 

explain in the Federal Register its 

reasons for not taking action. 

Persons who export or intend to 

export a chemical substance identified 

in a proposed or final SNUR are subject 

to the export notification provisions of 

TSCA section 12(b). The regulations that 

interpret TSCA section 12(b) appear at 

40 CFR part 707, subpart D. Persons 

who import a chemical substance 

identified in a final SNUR are subject to 

the TSCA section 13 import certification 

requirements, codified at 19 CFR 12.118 

through 12.127 and 19 CFR 127.28. 

Such persons must certify that the 

shipment of the chemical substance 

complies with all applicable rules and 

orders under TSCA, including any 

SNUR requirements. The EPA policy on 

import certification appears at 40 CFR 

part 707, subpart B. 

III. Substances Subject to this Rule 

EPA is establishing significant new 

use and recordkeeping requirements for 

65 chemical substances under 40 CFR 

part 721, subpart E. In this unit, EPA 

provides the following information for 

each chemical substance: 

• PMN number. 

• Chemical name (generic name if the 

specific name is claimed as CBI). 

• CAS number (if assigned for nonconfidential chemical identities). 

• Basis for the section 5(e) consent 

order, or, for non-5(e) SNURs, the basis 

for the SNUR. 

• Toxicity concerns. 

• Tests recommended by EPA to 

provide sufficient information to 

evaluate the chemical substance (see 

Unit VI. for more information). 

• CFR citation assigned in the 

regulatory text section of this rule. 

The specific activities designated as 

significant new uses are listed in the 

regulatory text section of 40 CFR part 

721, subpart E. Certain new uses, 

including production limits and other 

uses designated in the rule are claimed 

as CBI. The procedure for obtaining 

confidential information is set out in 

Unit VII. 

This rule includes SNURs on 13 PMN 

substances that are subject to ‘‘riskbased’’ consent orders under TSCA 

section 5(e)(1)(A)(ii)(I) wherein EPA 

determined that activities associated 

with the PMN substances may present 

unreasonable risk to health or the 

environment. The consent orders 

require protective measures to limit 

exposures or otherwise mitigate the 

potential unreasonable risk. The socalled ‘‘5(e) SNURs’’ on these 

substances are promulgated pursuant to 

40 CFR 721.160, and are based on and 

consistent with the provisions in the 

underlying consent orders. The SNURs 

designate as a ‘‘significant new use’’ the 

absence of the protective measures 

required in the consent order. 

Where EPA determined that the PMN 

substance may present an unreasonable 

risk of injury to human health via 


cprice-sewell on PROD1PC61 with RULES
14684 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

inhalation exposure, the underlying 

section 5(e) consent order usually 

requires, among other things, that 

potentially exposed employees must 

wear specified respirators unless actual 

measurements of the workplace air 

show that air-borne concentrations of 

the PMN substance are below a New 

Chemical Exposure Limit (NCEL) that is 

established by EPA to provide adequate 

protection to human health. In addition 

to the actual NCEL concentration, the 

comprehensive NCELs provisions in 

section 5(e) consent orders, which are 

modeled after Occupational Safety and 

Health Administration (OSHA) 

Permissible Exposure Limits (PELs) 

provisions, include requirements 

addressing performance criteria for 

sampling and analytical methods, 

periodic monitoring, respiratory 

protection, and recordkeeping. 

However, no comparable NCELs 

provisions currently exist in 40 CFR 

part 721, subpart B for SNURs. 

Therefore, for these cases, the 

individual SNURs in subpart E state that 

persons subject to the SNUR who wish 

to pursue NCELs as an alternative to the 

§ 721.63 respirator requirements may 

request to do so under 40 CFR 721.30. 

Persons whose § 721.30 requests to use 

the NCELs approach are approved by 

EPA will receive NCELs provisions 

comparable to those contained in the 

corresponding section 5(e) consent 

order for the same chemical substance 

for SNURs. 

This rule also includes SNURs on 52 

PMN substances that are not subject to 

consent orders under TSCA section 5(e). 

In these cases, EPA did not find that the 

use scenario described in the PMN 

triggered the determinations set forth 

under section 5(e) of TSCA. EPA, 

however, does believe that certain 

changes from the use scenario described 

in the PMN could result in increased 

exposures, thereby constituting a 

‘‘significant new use.’’ These so called 

‘‘Non-5(e) SNURs’’ are promulgated 

pursuant to 40 CFR 721.170. EPA has 

determined that every activity 

designated as a ‘‘significant new use’’ in 

all non-5(e) SNURs issued under 40 CFR 

721.170 satisfies the two requirements 

stipulated in § 721.170(c)(2), i.e., these 

significant new use activities, ‘‘(i) are 

different from those described in the 

premanufacture notice for the 

substance, including any amendments, 

deletions, and additions of activities to 

the premanufacture notice, and (ii) may 

be accompanied by changes in exposure 

or release levels that are significant in 

relation to the health or environmental 

concerns identified’’ for the PMN 

substance. 

PMN Number P–97–415 

Chemical name: 2-Thiazolidinone. 

CAS number: 2682–49–7. 

Effective date of section 5(e) consent 

order: April 20, 2000. 

Basis for section 5(e) consent order: The 

PMN states that the substance will be 

used as an intermediate. The order was 

issued under section 5(e)(1)(A)(i) and 

(ii)(I) of TSCA based on a finding that 

this substance may present an 

unreasonable risk of injury to health and 

the environment. To protect against this 

risk, the consent order requires worker 

protection and hazard communication 

and restricts disposal, water releases, 

and aggregate manufacture/importation 

volume of the PMN substance. It also 

prohibits use of the PMN substance 

other than as an intermediate and 

prohibits domestic manufacturing, 

processing, or use of the PMN substance 

as a powder. The SNUR designates as a 

‘significant new use’ the absence of 

these protective measures. 

Toxicity concern: EPA has identified 

health concerns for high acute toxicity 

and signs of neurotoxic effects based on 

test data for the PMN substance. EPA 

also has concerns for chronic effects and 

systemic, developmental, and maternal 

toxicity based on test data on a 

structurally similar substance. The 

NCEL is 0.7 mg/m3 as an 8-hour timeweighted average. EPA is concerned that 

toxicity to aquatic organisms may occur 

at concentrations as low as 300 parts per 

billion (ppb) of the PMN substance in 

surface waters based on test data on a 

structurally similar substance. 

Recommended testing: EPA has 

determined that the following test 

would help characterize the human 

health effects of the PMN substance: A 

combined repeated dose toxicity with 

the reproductive/developmental toxicity 

screening test (oral route) (OPPTS 

870.3650 test guideline) with a 

neurotoxicity functional observational 

battery (National Technical Information 

Service (NTIS) PB 91–154617) and a 

histopathologic examination extended 

to include the blood, liver, kidney, 

brain, and spinal cord on the PMN 

substance to help characterize 

neurotoxic, systemic, reproductive, and 

developmental effects. The PMN 

submitter has agreed not to exceed the 

production volume limit without 

performing this test. In addition, EPA 

has determined that a porous pot test 

(OPPTS 835.3220 test guideline), a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10002. 

PMN Numbers P–98–625/626/627/628/ 

629 and P–00–614/617 

Chemical name: Manganese 

heterocyclic tetraamine complex 

(generic). 

CAS number: Not available. 

Basis for action: The PMNs state that the 

generic (non-confidential) use of the 

substances will be in commercial 

research and development. EPA has 

identified health concerns for chronic 

organ effects based on data on a 

structurally similar substance. Since 

significant worker exposure is unlikely 

at the production volume identified in 

the PMNs, EPA has not determined that 

the proposed manufacture, processing, 

or use of the substances may present an 

unreasonable risk. EPA has determined, 

however, that a manufacture or 

importation volume greater than 10,000 

kilograms/year of any one of the PMN 

substances may result in serious chronic 

effects. Based on this information, each 

of the PMN substances meet the concern 

criteria at § 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 

oral toxicity study (OPPTS 870.3100 test 

guideline) would help characterize the 

human health effects of the PMN 

substances. 

CFR citation: 40 CFR 721.10003. 

PMN Number P–98–1181 

Chemical name: 2-Butenoic acid, 4,4′- 

[(dibutylstannylene)bis(oxy)]bis[4-oxo-, 

(2Z,2′Z)-, di-C8-10-isoalkyl esters, C9- 

rich. 

CAS number: 247041–56–1. 

Basis for action: The PMN states that the 

substance will be used as a polyvinyl 

chloride stabilizer. EPA has identified 

concerns for corrosion to skin, eyes, and 

mucuous membranes, neurotoxicity, 

blood toxicity, liver toxicity, 

immunosupression, reproductive 

toxicity, and adrenal effects based on 

analogy to organotins. As described in 

the PMN, significant worker exposure is 

unlikely. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

uses of the substance in a solid form, 

involving an application method that 

generates a vapor, mist, or aerosol, or 

where there is potential dermal 

exposure without the use of impervious 

gloves, may cause serious health effects. 

Based on this information, the PMN 

substance meets the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14685 

oral toxicity study (OPPTS 870.3100 test 

guideline) and a neurotoxicity screening 

test (OPPTS 870.6200 test guideline) 

would help characterize the human 

health effects of the PMN substance. 

CFR citation: 40 CFR 721.10004. 

PMN Number P–98–1182 

Chemical name: 2-Butenoic acid, 4,4′- 

[(dibutylstannylene)bis(oxy)]bis[4-oxo-, 

(2Z,2′Z)-, di-C9-11-isoalkyl esters, C10- 

rich. 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a polyvinyl 

chloride stabilizer. EPA has identified 

concerns for corrosion to skin, eyes, and 

mucuous membranes, neurotoxicity, 

blood toxicity, liver toxicity, 

immunosupression, reproductive 

toxicity, and adrenal effects based on 

analogy to organotins. As described in 

the PMN, significant worker exposure is 

unlikely. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

uses of the substance in a solid form, 

involving an application method that 

generates a vapor, mist, or aerosol, or 

where there is potential dermal 

exposure without the use of impervious 

gloves, may cause serious health effects. 

Based on this information, the PMN 

substance meets the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that the results of a 90-day 

oral toxicity study (OPPTS 870.3100 test 

guideline) and a neurotoxicity screening 

test (OPPTS 870.6200 test guideline) 

would help characterize the human 

health effects of the PMN substance. 

CFR citation: 40 CFR 721.10005. 

PMN Number P–99–511 

Chemical name: Mixed metal oxide 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as an additive for 

coatings. Based on data for a similar 

substance, EPA has identified concerns 

for cancer, immunotoxicity, and lung 

toxicity. As described in the PMN, 

significant inhalation exposure is 

unlikely. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

a manufacture/importation volume 

greater than 60,000 kilograms/year of 

the PMN substance may cause serious 

health effects. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(1)(i)(C) and (b)(3)(ii). 

Recommended testing: EPA has 

determined that a bacterial reverse 

mutation test (OPPTS 870.5100 test 

guideline) and a mammalian erythrocyte 

micronucleus test (intraperitoneal route) 

(OPPTS 870.5395 test guideline) with 

special attention to histopathology of 

the lung tissues and organs of the 

immune systems (spleen, thymus, bone 

marrow) would help characterize the 

human health effects of the PMN 

substance. If the results of the 

recommended tests indicate that the 

PMN substance has carcinogenic 

potential, a carcinogenicity study 

(OPPTS 870.4200 test guideline) would 

help further characterize the health 

effects. 

CFR citation: 40 CFR 721.10006. 

PMN Number P–00–11 

Chemical name: Alcohols, C12-14 - 

secondary, ethoxylated propoxylated. 

CAS number: 103331–86–8. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a household 

cleaning agent additive. Based on 

analogy to nonionic surfactants, EPA is 

concerned that toxicity to aquatic 

organisms may occur at concentrations 

above 50 ppb in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations above 50 

ppb. Thus, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in surface water 

concentrations above 50 ppb may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and an algal toxicity test (OPPTS 

850.5400 test guideline (public draft)) 

would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10007. 

PMN Numbers P–00–1121/1122/1123/ 

1124/1125/1126 

Chemical names: (P–00–1121) 

Manganese strontium oxide (MnSrO3); 

(P–00–1122) Manganese yttrium oxide 

(MnYO3); (P–00–1123) Barium 

manganese oxide (BaMnO3); (P–00–

1124) Barium calcium manganese 

strontium oxide; (P–00–1125) 

Manganate (MnO2

1-), calcium (2:1); and 

(P–00–1126) Manganese yttrium oxide 

(Mn2YO5). 

CAS numbers: (P–00–1121) 12163–45–

0, (P–00–1122) 12032–75–6, (P–00–

1123) 12230–80–7, (P–00–1124) 

359427–90–0, (P–00–1125) 12049–47–7, 

and (P–00–1126) 12438–71–0. 

Effective date of section 5(e) consent 

order: March 23, 2001. 

Basis for section 5(e) consent order: The 

PMNs state that the generic (nonconfidential) use of the substances will 

be as pigments. The order was issued 

under section 5(e)(1)(A)(i) and 

(e)(1)(A)(ii)(I) of TSCA based on a 

finding that these substances may 

present an unreasonable risk of injury to 

human health and the environment. To 

protect against this risk, the consent 

order requires hazard communication 

and restricts aggregate manufacture/ 

importation volume, particle size and 

water releases of the PMN substances. 

The SNUR designates as a ‘significant 

new use’ the absence of these protective 

measures. 

Toxicity concern: EPA has health 

concerns for neurotoxicity and 

mutagenicity for the PMN substances 

based on exposure to manganese; 

concerns for lung toxicity, fibrosis, and 

possible cancer of the lungs due to 

potential exposure to the particulate 

form of the substances; and concern for 

lung effects through lung overload if 

respirable particles are inhaled. Based 

on test data on structurally similar 

substances, EPA is concerned that 

toxicity to aquatic organisms for each of 

these PMN substances may occur at 

concentrations as low as 100 ppb in 

surface waters. Further, the Agency has 

determined that the PMN substances 

may be persistant, bioaccumulative, and 

toxic based on physical/chemical 

properties of the substances, consistent 

with the New Chemical Program’s 

Persistant, Bioaccumulative, and Toxic 

(PBT) Category (64 FR 60194, November 

4, 1999) (FRL–6097–7). Because of the 

potential PBT nature of the PMN 

substances, bioaccumulation and the 

potential for eventual exposure to 

humans and wildlife could result from 

exposure to concentrations below 100 

ppb. Therefore, to adequately mitigate 

this concern, EPA has decided to limit 

surface water concentrations resulting 

from manufacturing, processing, or use 

to 1 ppb or less for each of the PMN 

substances. 

Recommended testing: EPA has 

determined that a fish bioconcentration 

factor (BCF) test (OPPTS 850.1730 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the substances. The PMN submitter has 


cprice-sewell on PROD1PC61 with RULES
14686 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

agreed not to exceed the production 

volume limit without performing the 

fish BCF test on P–00–1122 or P–00–

1126. EPA has determined that a 90-day 

inhalation toxicity study in rats with a 

60-day holding period with special 

attention to the histopathology of the 

lungs (OPPTS 870.3465 test guideline) 

would help characterize the human 

health effects of the PMN substances. 

Based on the results of the 90-day study, 

a 2-year inhalation carcinogenicity test 

(OPPTS 870.4200 test guideline) may be 

warranted. 

CFR citations: 40 CFR 721.10008 (P–00–

1121); 40 CFR 721.10009 (P–00–1122); 

40 CFR 721.10010 (P–00–1123); 40 CFR 

721.10011 (P–00–1124); 40 CFR 

721.10012 (P–00–1125); and 40 CFR 

721.10013 (P–00–1126). 

PMN Number P–01–109 

Chemical name: Halogenated naphthalic 

anhydride (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a dye 

intermediate. Based on toxicity data on 

structurally similar chemicals, EPA 

expects toxicity to aquatic organisms to 

occur at concentrations as low as 20 ppb 

of the PMN substance in surface waters. 

As described in the PMN, the substance 

is not released to surface waters. 

Therefore, EPA has not determined that 

the proposed processing or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

releases to surface waters may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of the 

following testing would help 

characterize the PMN substance: An 

algal toxicity test (OPPTS 850.5400 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)). 

CFR citation: 40 CFR 721.10014. 

PMN Number P–01–110 

Chemical name: Halogenated 

benzimidazole (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a dye 

intermediate. Based on Structure 

Activity Relationships (SAR) analysis, 

EPA expects toxicity to aquatic 

organisms to occur at concentrations as 

low as 1 ppb of the PMN substance in 

surface waters. In addition, EPA has 

identified environmental concerns 

because the PMN substance may be 

persistent, bioaccumulative, and toxic 

based on physical/chemical properties 

of the PMN substance, consistent with 

the New Chemical Program’s PBT 

Category (64 FR 60194, November 4, 

1999). As described in the PMN, the 

substance is not released to surface 

waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

release of the PMN substance to surface 

waters may cause significant adverse 

environmental effects, since the PMN 

substance has been characterized by 

EPA as a PBT. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of the 

following tiered testing would help 

characterize the PMN substance: Tier 1 

- Melting point/melting range test 

(OPPTS 830.7200 test guideline) and an 

octanol water partition coefficient/Kow

test (OPPTS 830.7550 test guideline); 

Tier 2 - Activated sludge sorption 

isotherm (OPPTS 835.1110 test 

guideline) or modified coagulationflocculation jar test of water (D2034–80); 

Tier 3 - An algal toxicity test (OPPTS 

850.5400 test guideline (public draft)), a 

daphnid acute toxicity test (OPPTS 

850.1010 test guideline (public draft)) 

and a fish acute toxicity test (OPPTS 

850.1075 test guideline (public draft)); 

Tier 4 - tiered testing as described in the 

New Chemicals Program’s PBT Category 

(excluding the octanol water partition 

coefficient/Kow test already 

recommended in Tier 1). 

CFR citation: 40 CFR 721.10015. 

PMN Number P–01–111 

Chemical name: 

Dibenzimidazothianaphthalene 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a fluorescent 

dye. Based on toxicity data on 

structurally similar chemicals, EPA 

expects chronic toxicity to aquatic 

organisms to occur at concentrations as 

low as 1 ppb of the PMN substance in 

surface waters. As described in the 

PMN, the substance is not released to 

surface waters. Therefore, EPA has not 

determined that the proposed 

processing or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that releases to 

surface waters may cause significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of the 

following tiered testing would help 

characterize the PMN substance: Tier 1 

- Activated sludge sorption isotherm test 

(OPPTS 835.1110 test guideline) or 

modified coagulation-flocculation jar 

test of water (D2034–80); Tier 2 - An 

algal toxicity test (OPPTS 850.5400 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)); and Tier 3 - A 

daphnid chronic toxicity test (OPPTS 

850.1300 test guideline (public draft)) 

and a fish early-life stage toxicity test 

(OPPTS 850.1400 test guideline (public 

draft)). 

CFR citation: 40 CFR 721.10016. 

PMN Numbers P–01–257/258/259 and 

P–01–261 

Chemical name: Amine terminated 

bisphenol A diglycidyl ether polymer 

(generic). 

CAS number: Not available. 

Basis for action: The PMNs state that the 

substances will be used as epoxy resin 

curing agents. Based on analogy to 

structurally similar polycationic 

polymers, EPA is concerned that 

toxicity to aquatic organisms may occur 

at concentrations as low as 40 ppb in 

surface waters. As described in the 

PMNs, the substances are not released to 

surface waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substances may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substances resulting in 

release to surface waters may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substances meet the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), a fish acute toxicity test (OPPTS 

850.1075 test guideline (public draft)), 

and a fish acute toxicity test mitigated 

by humic acid (OPPTS 850.1085 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substances. 

CFR citation: 40 CFR 721.10017. 

PMN Number P–01–442 

Chemical name: Calcium hydroxide 

oxide silicate (Ca6(OH)2O2(Si2O5)3). 

CAS number: 13169–90–9. 

Basis for action: The PMN states that the 

substance will be used as a filler to 

reinforce resins, an additive for resins, 

and a filter medium. Based on test data 

on this chemical and structurally 

similar compounds, EPA has identified 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14687 

human health concerns for cancer and 

toxicity to the respiratory tract, lungs, 

respiratory system, and liver to workers 

exposed via inhalation. As described in 

the PMN, significant worker exposure is 

unlikely. Therefore, EPA has not 

determined that the proposed import, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that domestic 

manufacture, uses other than as 

described in the PMN, or processing or 

use as a powder resulting in significant 

worker inhalation exposure may cause 

significant adverse human health 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170 (b)(1)(i)(C), (b)(3)(i), 

and (b)(3)(ii). 

Recommended testing: EPA has 

determined that a 90-day inhalation 

toxicity study (OPPTS 870.3465 test 

guideline) would help characterize the 

human health effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10018. 

PMN Number P–01–563 

Chemical name: Benzoic acid, 2-chloro5-nitro-, 1,1-dimethyl-2-oxo-2-(2- 

propenyloxy) ethyl ester. 

CAS number: 174489–76–0. 

Basis for action: The PMN states that the 

substance will be used as a chemical 

intermediate. Based on submitted test 

data and on structural analogy to esters, 

EPA is concerned that toxicity to 

aquatic organisms may occur at 

concentrations as low as 3 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in release to 

surface waters may cause significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at § 721.170 

(b)(4)(i) and (b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), an algal toxicity test (OPPTS 

850.5400 test guideline (public draft)), 

and an aerobic aquatic biodegradation 

test with an analytical methodology to 

identify the isononyl phenol 

degradation product (OPPTS 835.3100 

test guideline) would help characterize 

the environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10019. 

PMN Number P–01–564 

Chemical name: Benzoic acid, 5-amino2-chloro-, 1,1-dimethyl-2-oxo-2-(2- 

propenyloxy) ethyl ester. 

CAS number: 174489–43–1. 

Basis for action: The PMN states that the 

substance will be used as a chemical 

intermediate. Based on structural 

analogy to anilines, EPA is concerned 

that toxicity to aquatic organisms may 

occur at concentrations as low as 1 ppb 

of the PMN substance in surface waters. 

As described in the PMN, the substance 

is not released to surface waters. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in release to 

surface waters may cause significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), an algal toxicity test (OPPTS 

850.5400 test guideline (public draft)), 

and an aerobic aquatic biodegradation 

test with an analytical methodology to 

identify the isononyl phenol 

degradation product (OPPTS 835.3100 

test guideline) would help characterize 

the environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10020. 

PMN Number P–01–764 

Chemical name: Magnesium potassium 

titanium oxide. 

CAS number:39290–90–9. 

Effective date of section 5(e) consent 

order: July 29, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the generic (nonconfidential) use of the substance will 

be as a physical characteristics modifier 

for industrial use in certain solid 

composite articles. The order was issued 

under section 5(e)(1)(A)(i) and 

(e)(1)(A)(ii)(I) of TSCA based on a 

finding that this substance may present 

an unreasonable risk of injury to human 

health. To protect against this risk, the 

consent order requires worker 

protection and hazard communication 

and restricts the aggregate manufacture/ 

importation volume of the PMN 

substance. The SNUR designates as a 

‘significant new use’ the absence of 

these protective measures. 

Toxicity concern: Based on test data on 

titanium dioxide, EPA has health 

concerns for lung toxicity, including 

lung overload and oncogenicity, with 

inhalation exposure. The NCEL is 5 mg/ 

m3 as an 8-hour time-weighted average. 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity study with a 60-day 

holding period (OPPTS 870.3465 test 

guideline) and possibly a 2-year 

carcinogenicity study (OPPTS 870.4200 

test guideline) would help characterize 

the human health effects of the PMN 

substance. The consent order contains 

two production volume limits. The 

PMN submitter agreed not to exceed the 

first production volume limit without 

performing the 90-day inhalation 

toxicity study and not to exceed the 

second production volume limit 

without performing the 2-year 

carcinogenicity study if warranted based 

on the results of the first study. 

CFR citation: 40 CFR 721.10021. 

PMN Numbers P–01–769/770/771/772 

Chemical names: (P–01–769) 

Benzenamine, N-phenyl-, ar-(C9-rich 

C8-10-branched alkyl) derivs; (P–01–770) 

Benzenamine, N-phenyl-, ar, ar′-(C9-rich 

C8-10-branched alkyl) derivs; (P–01–771) 

10H-Phenothiazine, ar-(C9-rich C8-10- 

branched alkyl) derivs; and (P–01–772) 

10H-Phenothiazine, ar, ar′-(C9-rich C8-10- 

branched alkyl) derivs. 

CAS numbers: (P–01–769) 333955–69–

4, (P–01–770) 333955–70–7, (P–01–771) 

333955–79–6, and (P–01–772) 333955–

80–9. 

Basis for action: The PMNs state that the 

substances will be used as antioxidants 

for lubricating oils. EPA has identified 

human health and environmental 

concerns because the PMN substances 

may be persistent, bioaccumulative, and 

toxic, based on submitted test data and 

physical/chemical properties of the 

PMN substances, consistent with the 

New Chemical Program’s PBT Category 

(64 FR 60194, November 4, 1999). As 

described in the PMNs, significant 

worker exposure is unlikely and the 

substances are not released to surface 

waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

PMN substances may present an 

unreasonable risk. EPA has determined, 

however, that use of the PMN 

substances other than as described in 

the PMNs resulting in release to water 

may cause serious chronic human 

health effects and significant 

environmental effects, since the PMN 

substances have been characterized by 

EPA as a PBT. Based on this 

information, the PMN substances meet 

the concern criteria at § 721.170 (b)(3)(i), 

(b)(4)(ii), and (b)(4)(iii). 

Recommended testing: EPA has 

determined that the results of testing 

Tiers 2 and 3 as described in the New 


cprice-sewell on PROD1PC61 with RULES
14688 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

Chemicals Program’s PBT Category 

would help characterize the PBT 

attributes of the PMN substances. 

CFR citations: 40 CFR 721.10022 (P–01–

769); 40 CFR 721.10023 (P–01–770); 40 

CFR 721.10024 (P–01–771); and 40 CFR 

721.10025 (P–01–772). 

PMN Number P–01–856 

Chemical name: Cashew, nutshell liq., 

ethoxylated. 

CAS number: 350820–95–0. 

Effective date of section 5(e) consent 

order: July 5, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the substance will be 

used as a pigment dispersant. The order 

was issued under section 5(e)(1)(A)(i) 

and (e)(1)(A)(ii)(I) of TSCA based on a 

finding that this substance may present 

an unreasonable risk of injury to the 

environment. To protect against this 

risk, the consent order restricts 

molecular weight and composition of 

the PMN substance. The SNUR 

designates as a ‘significant new use’ the 

absence of these protective measures. 

Toxicity concern: Based on test data on 

structurally similar nonionic 

surfactants, particularly alkyl 

ethoxylate, EPA has concerns that the 

environmental toxicity of the PMN 

substance varies depending on the 

average number of moles of the ethoxy. 

As the number of moles of ethoxy 

decreases, the aquatic toxicity of the 

substance increases. For this PMN 

substance, the average number of moles 

may vary. When the average number of 

moles of the ethoxy group is 80, EPA 

expects toxicity to aquatic organisms to 

occur at concentrations as low as 1,000 

ppb. 

Recommended testing: The Agency has 

determined that the results of a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize possible environmental 

effects of the substance. The tests 

should be conducted on the PMN 

substance with less than 55 moles of the 

ethoxy group or with an average 

molecular weight less than 2,700 

daltons. 

CFR citation: 40 CFR 721.10026. 

PMN Number P–01–862 

Chemical name: Ethoxylated 

alkylsulfate, substituted alkylamine salt 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a processing aid. 

Based on analogy to cationic surfactants 

and similar substances, EPA is 

concerned that chronic toxicity to 

aquatic organisms may occur at 

concentrations as low as 4 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters in 

significant quantities. Therefore, EPA 

has not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

significant release to surface waters may 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish early-life stage 

toxicity test (OPPTS 850.1400 test 

guideline (public draft)), a daphnid 

chronic toxicity test (OPPTS 850.1300 

test guideline (public draft)), and a 

ready biodegradability test (OPPTS 

835.3110 test guideline) would help 

characterize the chronic environmental 

effects and the fate in the environment 

of the PMN substance. After this testing 

is completed, if the results of the testing 

and projected environmental risk 

warrant it, a porous pot test (OPPTS 

835.3220 test guideline) or modified 

semi-continuous activated sludge 

(SCAS) test (OPPTS 835.3210 test 

guideline) would further characterize 

the environmental fate of this substance. 

CFR citation: 40 CFR 721.10027. 

PMN Numbers P–01–901 and P–01–902 

Chemical name: Disubstituted benzene 

metal salt (generic). 

CAS number: Not available. 

Basis for action: The PMNs state that the 

generic (non-confidential) use of the 

substances will be as a polymer 

additive. Based on test data and analogy 

to phenols and hydroquinones/ 

quinones, EPA has concerns for dermal 

corrosivity, acute toxicity, kidney and 

liver effects, mutagenicity, 

carcinogenicity, neurotoxicity, 

developmental toxicity, depigmentation 

of skin, thyroid effects, and 

sensitization. Also, based on analogy to 

phenols and hydroquinones/quinones, 

EPA is concerned that toxicity to 

aquatic organisms may occur at 

concentrations as low as 1 ppb in 

surface waters. As described in the 

PMNs, significant worker exposure is 

not expected as workers wear 

impervious personal protective 

equipment and significant 

environmental exposure is not expected 

as the substances are not released to 

surface waters in significant quantities. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substances may 

present an unreasonable risk. EPA has 

determined, however, that use of the 

substances without workers wearing 

impervious gloves or uses other than as 

described in the PMNs could result in 

serious health effects or significant 

adverse environmental effects. Based on 

this information, the PMN substances 

meet the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(3)(i), (b)(3)(ii), and 

(b)(4)(ii). 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)) would help characterize the 

environmental effects of the PMN 

substances. EPA has also determined 

that a 90-day inhalation toxicity study 

with a 60-day holding period (OPPTS 

870.3465 test guideline) would help 

characterize the human health effects. 

CFR citation: 40 CFR 721.10028. 

PMN Number P–01–918 

Chemical name: Isocyanate compound, 

modified with methoxysilane (generic). 

CAS number: Not available. 

Effective date of section 5(e) consent 

order: May 30, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the generic (nonconfidential) use of the substance will 

be as a sealant. The order was issued 

under section 5(e)(1)(A)(i) and 

(e)(1)(A)(ii)(I) of TSCA based on a 

finding that this substance may present 

an unreasonable risk of injury to human 

health. To protect against this risk, the 

consent order requires worker 

protection and hazard communication 

and restricts the aggregate manufacture/ 

importation volume of the PMN 

substance. The SNUR designates as a 

‘significant new use’ the absence of 

these protective measures. 

Toxicity concern: Based on test data on 

diisocyanates, the Agency has concern 

for dermal and respiratory sensitization 

and pulmonary toxicity. The NCEL is 

0.05 mg/m3 or 0.005 ppm as an 8-hour 

time-weighted average. 

Recommended testing: EPA has 

determined that the results of a skin 

sensitization study (OPPTS 870.2600 

test guideline) and a 90-day inhalation 

toxicity study (OPPTS 870.3465 test 

guideline) would help characterize the 

human health effects of the substance. 

CFR citation: 40 CFR 721.10029. 

PMN Number P–01–919 

Chemical name: Pyrimido[5,4- 

g]pteridine-2,4,6,8-tetramine, 4- 

methylbenzenesulfonate, basehydrolyzed. 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14689 

CAS number: 346709–25–9. 

Basis for action: The PMN states that the 

substance will be used as a pigment for 

thermoplastic polymers. Based on 

analogy to structurally similar Nheterocyclic chemicals, EPA has 

concerns for potential developmental 

toxicity from exposure to the PMN 

material. Significant worker exposure is 

unlikely when the substance is used as 

described in the PMN. In addition, 

based on test data on the PMN 

substance, EPA is concerned that 

chronic toxicity to aquatic organisms 

may occur at concentrations as low as 

10 ppb in surface waters. As described 

in the PMN, the substance is not 

released to surface waters in significant 

quantities. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

domestic manufacture of the substance 

may cause serious health effects and 

significant environmental effects. Based 

on this information, the PMN substance 

meets the concern criteria at § 721.170 

(b)(3)(ii) and (b)(4)(i). 

Recommended testing: EPA has 

determined that a combined repeated 

dose toxicity study with the 

reproduction/developmental toxicity 

screening test (OPPTS 870.3650 test 

guideline), a daphnid chronic toxicity 

test (OPPTS 850.1300 test guideline 

(public draft)), and a fish early-life stage 

toxicity test (OPPTS 850.1400 test 

guideline (public draft)) would help 

characterize the human health and 

environmental effects of the substance. 

CFR citation: 40 CFR 721.10030. 

PMN Number P–02–214 

Chemical name: Lithium potassium 

titanium oxide. 

CAS number: 39318–30–4. 

Effective date of section 5(e) consent 

order: June 17, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the generic (nonconfidential) use of the substance will 

be as a physical characteristics modifier 

for industrial use in certain solid 

composite articles. The order was issued 

under section 5(e)(1)(A)(i) and 

(e)(1)(A)(ii)(I) of TSCA based on a 

finding that this substance may present 

an unreasonable risk of injury to human 

health. To protect against this risk, the 

consent order requires worker 

protection and hazard communication 

and restricts the aggregate manufacture/ 

importation volume of the PMN 

substance. The SNUR designates as a 

‘significant new use’ the absence of 

these protective measures. 

Toxicity concern: Based on test data on 

titanium dioxide, the Agency has 

concerns for lung toxicity (including 

oncogenicity) if the PMN substance is 

inhaled. The NCEL is 5 mg/m3 as an 8- 

hour time-weighted average. 

Recommended testing: EPA has 

determined that the results of a 90-day 

inhalation toxicity study with a 60-day 

holding period (OPPTS 870.3465 test 

guideline) and possibly a 2-year 

carcinogenicity study (OPPTS 870.4200 

test guideline) would help characterize 

the human health effects of the PMN 

substance. The consent order contains 

two production volume limits. The 

PMN submitter agreed not to exceed the 

first production volume limit without 

performing the 90-day inhalation 

toxicity study and not to exceed the 

second production volume limit 

without performing the 2-year 

carcinogenicity study if warranted based 

on the results of the first study. 

CFR citation: 40 CFR 721.10031. 

PMN Number P–02–269 

Chemical name: Acrylic acid, polymer 

with substituted acrylamides (generic). 

CAS number: Not available. 

Effective date of section 5(e) consent 

order: October 22, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the generic (nonconfidential) use of the substance will 

be as a thermo-sensitive water 

absorbing/desorbing polymer to soil. 

The order was issued under section 

5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA 

based on a finding that this substance 

may present an unreasonable risk of 

injury to human health. To protect 

against this risk, the consent order 

restricts the particle size of the PMN 

substance. The SNUR designates as a 

‘significant new use’ the absence of this 

protective measure. 

Toxicity concern: Based on test data on 

swellable high molecular weight 

polymers (see 60 FR 16319–16320, 

March 29, 1995) (FRl–4921–9), the 

Agency has concerns for lung toxicity 

and oncogenicity if the PMN substance 

is inhaled. 

Recommended testing: The Agency has 

determined that a 90-day inhalation 

toxicity study (OPPTS 870.3465 test 

guideline) and a carcinogenicity study 

(OPPTS 870.4200 test guideline) would 

help characterize possible human health 

effects of the substance. 

CFR citation: 40 CFR 721.10032. 

PMN Number P–02–322 

Chemical name: Zinc, [ethanedioato(2-)- 

. kappa. O1, . kappa. O2]-. 

CAS number: 547–68–2. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as an intermediate. 

Based on analogy to similar zinc 

compounds, EPA is concerned that 

toxicity to aquatic organisms may occur 

at concentrations above 1 ppb in surface 

waters. As described in the PMN, 

releases of the substance are not 

expected to result in surface water 

concentrations above 1 ppb. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the PMN substance may cause 

significant adverse effects. EPA has 

determined, however, that other uses of 

the PMN substance resulting in surface 

water concentrations above 1 ppb may 

cause significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)), a fish early-life 

stage toxicity test (OPPTS 850.1400 test 

guideline (public draft)), and a daphnid 

chronic toxicity test (OPPTS 850.1300 

test guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10033. 

PMN Number P–02–359 

Chemical name: Substituted pyridine 

coupled with diazotized substituted 

nitrobenzonitrile, diazotized substituted 

benzenamine and substituted 

pyridinecarbonitrile (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a textile dye. Based 

on structural analogy to neutral 

organics, EPA is concerned that chronic 

toxicity to aquatic organisms may occur 

at concentrations above 1 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters in 

significant quantities. Therefore, EPA 

has not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

release to surface waters in 

concentrations above 1 ppb may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish early-life toxicity 

test (OPPTS 850.1400 test guideline 

(public draft)), a daphnid chronic 

toxicity test (OPPTS 850.1300 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10034. 

PMN Number P–02–382 

Chemical name: Alkylbenzene sulfonate 

(generic). 


cprice-sewell on PROD1PC61 with RULES
14690 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

CAS number: Not available. 

Effective date of section 5(e) consent 

order: December 17, 2002. 

Basis for section 5(e) consent order: The 

PMN states that the generic (nonconfidential) use of the substance will 

be as a petroleum lubricant additive. 

The order was issued under section 

5(e)(1)(A)(i) and (e)(1)(A)(ii)(I) of TSCA 

based on a finding that this substance 

may present an unreasonable risk of 

injury to the environment. To protect 

against this risk, the consent order 

restricts the formulation of the PMN 

substance. The SNUR designates as a 

‘significant new use’ the absence of this 

protective measure. In addition, the 

order was issued under section 

5(e)(1)(A)(ii)(II) of TSCA based on a 

finding that this substance will be 

produced in substantial quantities and 

may reasonably be anticipated to enter 

the environment in substantial 

quantities. 

Toxicity concern: Based on analogy to 

structurally similar anionic surfactants, 

EPA expects toxicity to aquatic 

organisms to occur at concentrations as 

low as 500 ppb in surface waters. 

However, when the PMN substance is 

manufactured, processed, and used in 

mineral oil as described in the PMN, 

EPA does not expect releases of this 

PMN substance to pose a risk to the 

environment. The oil diluent serves to 

minimize dispersion and bioavailability 

of the PMN substance in surface waters. 

EPA has determined that other uses of 

the substance when not diluted in 

mineral oil may result in significant 

release to surface waters and may cause 

significant adverse environmental 

effects. 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)) would help characterize the 

environmental effects of the PMN 

substance when not used in mineral oil. 

CFR citation: 40 CFR 721.10035. 

PMN Number P–02–406 

Chemical name: Acetaldehyde based 

polymer (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a corrosion 

inhibitor. EPA has identified health and 

environmental concerns for this 

substance. EPA has identified health 

concerns for carcinogenicity and dermal 

sensitization based on analogy to 

structurally similar chemicals. Based on 

structural analogy to aldehydes, EPA is 

concerned that toxicity to aquatic 

organisms may occur at concentrations 

as low as 1 ppb of the PMN substance 

in surface waters. In addition, the PMN 

substance may be persistent, 

bioaccumulative, and potentially toxic 

based on physical/chemical properties 

of the PMN substance as described in 

the New Chemical Program’s PBT 

Category (64 FR 60194, November 4, 

1999). As described in the PMN, 

significant worker exposure is unlikely 

and the substance is not released to 

surface waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

PMN substance may present an 

unreasonable risk. EPA has determined, 

however, that other domestic 

manufacturing or other uses that result 

in predictable or purposeful releases to 

surface water could result in exposures 

which may cause serious chronic 

human health effects and significant 

environmental effects since the 

substance has been characterized by 

EPA as a PBT. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(3)(ii), and (b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of the tiered 

testing as described in the New 

Chemicals Program’s PBT Category 

would help characterize the PBT 

attributes of the PMN substance. 

CFR citation: 40 CFR 721.10036. 

PMN Number P–02–423 

Chemical name: Complex halogenated 

salt of tris(ethylated 

aminocarbocyclic)methane (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a colorant for 

inks. Based on structurally similar 

compounds, EPA has identified human 

health concerns for carcinogenicity, 

mutagenicity, reproductive effects, and 

developmental effects from inhalation 

exposure to the PMN substance. In 

addition, based on structurally similar 

compounds, EPA expects toxicity to 

aquatic organisms at surface water 

concentrations above 1 ppb. As 

described in the PMN, significant 

worker and environmental exposure are 

unlikely. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

surface water concentrations above 1 

ppb or any processing or use beyond the 

site of manufacture or import could 

result in worker and environmental 

exposures which may cause 

carcinogenic and serious chronic effects 

in humans and significant 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(3)(ii), and (b)(4)(ii). 

Recommended testing: EPA has 

determined that a prenatal 

developmental toxicity study by the oral 

route (OPPTS 870.3700 test guideline), 

a reproductive and fertility effects study 

(OPPTS 870.3800 test guideline), a 

Salmonella typhimurium reverse 

mutation assay (40 CFR 798.5265), and 

a mammalian erythrocyte micronucleus 

study by the intraperitoneal route 

(OPPTS 870.5395 test guideline) would 

help characterize the human health 

effects of the PMN substance. Positive 

results in the mutagencity studies 

would trigger a carcinogenicity study 

(OPPTS 870.4200 test guideline). In 

addition, EPA has determined that a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10037. 

PMN Number P–02–434 

Chemical name: Trimellitic anhydride, 

polymer with substituted glycol, alkyl 

phenols and ethoxylated nonylphenol 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as curing resin 

for industrial can coatings. Based on 

structural analogy to esters, EPA is 

concerned that toxicity to aquatic 

organisms may occur at concentrations 

as low as 1 ppb of the PMN substance 

in surface waters. As described in the 

PMN, the substance is not released to 

surface waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

release to surface waters may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that an aerobic 

biodegradation test with an analytical 

methodology to identify the branchednonyl phenol degradation product 

(OPPTS 835.3100 test guideline) would 

help characterize the environmental 

effects of the PMN substance. 

CFR citation: 40 CFR 721.10038. 

PMN Number P–02–514 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14691 

Chemical name: Diethoxybenzenamine 

derivative, diazotized, coupled with 

aminonaphthalenesulfonic acid 

derivative, ammonium salt (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a dyestuff in 

printing ink. Based on structural 

analogy, EPA has identified concerns for 

carcinogenicity, mutagenicity, and 

developmental toxicity for the 

substituted beta-naphthylamine azo 

reduction product, blood and 

developmental toxicity for the anilineacid-based azo reduction product, and 

carcinogenicity, developmental, liver 

toxicity and sensitization for the paraphenylenediamine-based azo reduction 

product. There is concern for chronic 

effects based on the submitted 28-day 

subchronic study with a No Observed 

Adverse Effect Level (NOAEL) of 15 mg/ 

kg. As described in the PMN, worker 

inhalation exposures are not expected. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that domestic 

manufacture or processing or use of the 

substance as a solid may cause serious 

health effects. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(3)(i), (b)(3)(ii), and 

(b)(3)(iii). 

Recommended testing: EPA has 

determined that a prenatal 

developmental toxicity study by the oral 

route in two species (40 CFR 799.9370), 

an Ames assay with the Prival 

modification with a concurrent positive 

control (OPPTS 870.5100 test 

guideline), and a 90-day inhalation 

toxicity study in rats (OPPTS 870.3465 

test guideline) would help characterize 

the human health effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10039. 

PMN Number P–02–522 

Chemical name: Substituted acridine 

naphtha substituted benzamide 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be in exhaust dyeing of 

polyester fibers. Based on analogy to 

neutral organics, EPA is concerned that 

toxicity to aquatic organisms may occur 

at concentrations above 2 ppb of the 

PMN substance in surface waters. As 

described in the PMN, releases of the 

substance are not expected to result in 

surface water concentrations above 2 

ppb. Therefore, EPA has not determined 

that the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in release to 

surface waters in concentrations above 2 

ppb may cause significant adverse 

environmental effects. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)), a fish chronic 

toxicity test (OPPTS 850.1400 test 

guideline (public draft)), and a daphnid 

chronic toxicity test (OPPTS 850.1300 

test guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10040. 

PMN Number P–02–530 

Chemical name: 1-Butanone, 2- 

(dimethylamino)-2-[(4- 

methylphenyl)methyl]-1-[4-(4- 

morpholinyl)phenyl]-. 

CAS number: 119344–86–4. 

Basis for action: The PMN states that the 

substance will be used as a photo 

initiator for coatings and inks. Based on 

structural analogy to aliphatic amines, 

EPA is concerned that toxicity to 

aquatic organisms may occur at 

concentrations as low as 2 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters in 

significant quantities. Therefore, EPA 

has not determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

domestic manufacture of the PMN 

substance may result in significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and an algal toxicity test (OPPTS 

850.5400 test guideline (public draft)) 

would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10041. 

PMN Number P–02–585 

Chemical name: 2-Propanol, 1-[bis(2- 

hydroxyethyl)amino]-. 

CAS number: 6712–98–7. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a grinding aid and 

intermediate. EPA has identified health 

concerns for lung sensitization and 

carcinogenicity based on analogy to 

triethanolamine. There is concern for 

developmental toxicity, eye irritation, 

liver toxicity, kidney toxicity, and blood 

toxicity based on submitted test data. As 

described in the PMN, significant 

inhalation exposure is unlikely. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance other than as described in 

the PMN may result in significant 

human exposure. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(3)(i), and (b)(3)(ii). 

Recommended testing: EPA has 

determined that a prenatal 

developmental toxicity study by the oral 

route in rats (OPPTS 870.3700 test 

guideline) would help characterize the 

human health effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10042. 

PMN Number P–02–697 

Chemical name: Dineopentyl-4- 

substituted phthalate (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a catalyst 

component. EPA has identified health 

and environmental concerns because 

the PMN substance may be persistent, 

bioaccumulative, and toxic based on 

physical/chemical properties of the 

PMN substance as described in the New 

Chemical Program’s PBT Category (64 

FR 60194, November 4, 1999). EPA has 

identified health concerns for 

developmental toxicity based on 

analogy to other phthalates and 

concerns for liver, kidney, and 

neurotoxicity based on analogy to 

haloaromatic compounds. As described 

in the PMN, significant worker exposure 

is unlikely and the substance is not 

released to surface waters. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the PMN substance may present 

an unreasonable risk. EPA has 

determined, however, that other uses of 

the PMN substance which may result in 

predictable or purposeful release of the 

PMN substance into waters of the 

United States or any use of the PMN 

substance other than as described in the 

PMN could result in exposures which 

may cause serious chronic human 

health effects and significant 


cprice-sewell on PROD1PC61 with RULES
14692 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

environmental effects since the PMN 

substance has been characterized by 

EPA as a PBT. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170 

(b)(3)(ii) and (b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of the tiered 

testing as described in the New 

Chemicals Program’s PBT Category 

would help characterize the PBT 

attributes of the PMN substance. 

CFR citation: 40 CFR 721.10043. 

PMN Number P–02–698 

Chemical name: Metal oxide, modified 

with alkyl and vinyl terminated 

polysiloxanes (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as an adhesive. 

EPA has identified health concerns for 

lung toxicity based on analogy to poorly 

soluble respirable particulates. As 

described in the PMN, significant 

worker exposure is unlikely. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the substance may present an 

unreasonable risk. EPA has determined, 

however, that manufacturing, 

processing, or use of the substance as a 

powder could result in exposures which 

may cause serious health effects. Based 

on this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that a 90-day inhalation 

toxicity study in rodents with a 60-day 

holding period (OPPTS 870.3465 test 

guideline) would help characterize the 

human health effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10044. 

PMN Number P–02–737 

Chemical name: Diazotized substituted 

heteromonocycle coupled with 

naphthalene sulfonic acid derivative, 

nickel complex, alkaline salt (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a colorant for 

coating compositions. EPA has 

identified concerns for carcinogenicity, 

pulmonary sensitization, 

immunotoxicity, developmental 

toxicity, and neurotoxicity from 

analogous compounds, and 

carcinogenicity, mutagenicity, and 

developmental toxicity for the azo 

reduction products. As described in the 

PMN, worker inhalation exposure is not 

expected. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

domestic manufacture or processing or 

use of the substance as a solid may 

cause serious health effects. Based on 

this information, the PMN substance 

meets the concern criteria at § 721.170 

(b)(1)(i)(C), (b)(1)(i)(D), (b)(3)(ii), and 

(b)(3)(iii). 

Recommended testing: EPA has 

determined that a 90-day oral toxicity 

test in rodents (OPPTS 870.3100 test 

guideline), a bacterial reverse mutation 

test with Prival modification (OPPTS 

870.5100 test guideline), and an 

unscheduled DNA synthesis test in rat 

hepatocytes (OPPTS 870.5550 test 

guideline) would help characterize the 

human health effects of the PMN 

substance. If warranted by the results of 

any of the three above studies, a 

carcinogenicity test (OPPTS 870.4200 

test guideline) is recommended. 

CFR citation: 40 CFR 721.10045. 

PMN Number P–02–747 

Chemical name: Polyaromatic amine 

phosphate (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a film 

additive. Based on structural analogy to 

soluble nonionic dyes and inorganic 

phosphates, EPA is concerned that 

toxicity to aquatic organisms may occur 

at concentrations as low as 10 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in release to 

surface waters may cause significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and an algal toxicity test (OPPTS 

850.5400 test guideline (public draft)) 

would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10046. 

PMN Number P–02–766 

Chemical name: Polyphosphoric acids, 

compds. with piperazine. 

CAS number: 383905–85–9. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a flame retardant. 

Based on analogy to aliphatic amines 

and inorganic phosphates, EPA is 

concerned that toxicity to aquatic 

organisms may occur at concentrations 

as low as 10 ppb of the PMN substance 

in surface waters. As described in the 

PMN, the substance is not released to 

surface waters in significant quantities. 

Therefore, EPA has not determined that 

the proposed manufacturing or use of 

the substance may present an 

unreasonable risk. EPA has determined, 

however, that use of the substance other 

than as described in the PMN could 

result in exposures which may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)) would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10047. 

PMN Number P–02–869 

Chemical name: Substituted 

anthraquinone (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as a site limited 

intermediate. Based on structural 

analogy to phenols, EPA is concerned 

that chronic toxicity to aquatic 

organisms may occur at concentrations 

above 1 ppb of the PMN substance in 

surface waters. As described in the 

PMN, releases of the substance are not 

expected to result in surface water 

concentrations above 1 ppb. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the substance may present an 

unreasonable risk. EPA has determined, 

however, that a manufacture/ 

importation volume greater than 4,500 

kilograms/year may result in significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish early life stage 

test (OPPTS 850.1400 test guideline 

(public draft)), a daphnid chronic 

toxicity test (OPPTS 850.1300 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10048. 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14693 

PMN Number P–02–912 

Chemical name: Phenol, 4,4′- 

cyclohexylidenebis[2-methyl-. 

CAS number: 2362–14–3. 

Basis for action: The PMN states that the 

substance will be used as a raw 

material. Based on structural analogy to 

phenols, EPA is concerned that chronic 

toxicity to aquatic organisms may occur 

at concentrations as low as 1 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface water. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the substance may present an 

unreasonable risk. EPA has determined, 

however, that any release of the PMN 

substance to surface water may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish early-life stage 

toxicity test (OPPTS 850.1400 test 

guideline (public draft)) and a daphnid 

chronic toxicity test (OPPTS 850.1300 

test guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10049. 

PMN Number P–02–929 

Chemical name: Disubstituted-N′- 

hydroxy-benzenecarboximidamide 

(generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

substance will be used as an 

intermediate. EPA has concerns for 

chronic toxicity to blood, kidney, and 

liver based on a submitted 28-day study. 

As described in the PMN, significant 

worker exposure is unlikely. Therefore, 

EPA has not determined that the 

proposed manufacturing, processing, or 

use of the substance may present an 

unreasonable risk. EPA determined, 

however, that use of the substance other 

than as an intermediate may result in 

exposures which may cause serious 

health effects. Based on this 

information, the PMN substance meets 

the concern criteria at § 721.170(b)(3)(i). 

Recommended testing: EPA has 

determined that a 90-day oral toxicity 

study in rodents by the gavage route 

(OPPTS 870.3100 test guideline) would 

help characterize the human health 

effects of the PMN substance. 

CFR citation: 40 CFR 721.10050. 

PMN Number P–02–961 

Chemical name: Spiro naphthoxazine 

(generic) 

. 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a colorant. Based 

on structural analogy to neutral organic 

chemicals, EPA expects chronic toxicity 

to aquatic organisms at concentrations 

as low as 1 ppb of the PMN substance 

in surface waters. As described in the 

PMN, the substance is not released to 

surface waters in significant quantities. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that domestic 

manufacture of the substance could 

result in exposures which may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that a fish early-life stage 

toxicity test (OPPTS 850.1400 test 

guideline (public draft)) and a daphnid 

chronic toxicity test (OPPTS 850.1300 

test guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10051. 

PMN Number P–02–1088 

Chemical name: Aminoalkyl substituted 

alkylphenol (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be in a destructive use. 

Based on structural analogy to phenols 

and aliphatic amines, EPA is concerned 

that toxicity to aquatic organisms may 

occur at concentrations as low as 1 ppb 

of the PMN substance in surface waters. 

As described in the PMN, the substance 

is not released to surface waters. 

Therefore, EPA has not determined that 

the proposed manufacturing or use of 

the substance may present an 

unreasonable risk. EPA has determined, 

however, that use of the substance other 

than as described in the PMN could 

result in exposures which may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), and a fish acute toxicity test 

(OPPTS 850.1075 test guideline (public 

draft)) would help characterize the 

environmental effects of the PMN 

substance. 

CFR citation: 40 CFR 721.10052. 

PMN Number P–03–41 

Chemical name: Alkyl silane 

methacrylate (generic). 

CAS number: Not available. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as a chemical 

intermediate. Based on structural 

analogy to methacrylates and esters, 

EPA is concerned that toxicity to 

aquatic organisms may occur at 

concentrations as low as 3 ppb of the 

PMN substance in surface waters. As 

described in the PMN, the substance is 

not released to surface waters. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance resulting in release to 

surface waters may cause significant 

adverse environmental effects. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that the results of a fish 

acute toxicity test (OPPTS 850.1075 test 

guideline (public draft)), a daphnid 

acute toxicity test (OPPTS 850.1010 test 

guideline (public draft)), and an algal 

toxicity test (OPPTS 850.5400 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10053. 

PMN Number P–03–43 

Chemical name: Phenol, polymer with 

formaldehyde, 3-[(2- 

aminocyclohexyl)amino]-2- 

hydroxypropyl ethers. 

CAS number: 452082–53–0. 

Basis for action:The PMN states that the 

generic (non-confidential) use of the 

substance will be as a resin component. 

Based on structural analogy to 

polycationic polymers, EPA is 

concerned that toxicity to aquatic 

organisms may occur at concentrations 

as low as 20 ppb of the PMN substance 

in surface waters. As described in the 

PMN, the substance is not released to 

surface waters. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance resulting in 

release to surface waters may cause 

significant adverse environmental 

effects. Based on this information, the 

PMN substance meets the concern 

criteria at § 721.170(b)(4)(ii). 

Recommended testing: EPA has 

determined that an algal toxicity test 

(OPPTS 850.5400 test guideline (public 

draft)), a daphnid acute toxicity test 

(OPPTS 850.1010 test guideline (public 

draft)), a fish acute toxicity test (OPPTS 

850.1075 test guideline (public draft)), 

and a fish acute toxicity test mitigated 


cprice-sewell on PROD1PC61 with RULES
14694 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

by humic acid (OPPTS 850.1085 test 

guideline (public draft)) would help 

characterize the environmental effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10054. 

PMN Number P–03–46 

Chemical name: 1-Propanaminium, 3- 

amino-N-(carboxymethyl)-N,Ndimethyl-, N-soya acyl derivs., inner 

salts. 

CAS number: 136504–87–5. 

Basis for action: The PMN states that the 

generic (non-confidential) use of the 

substance will be as an oilfield foamer. 

EPA has identified health concerns for 

developmental toxicity, neurotoxicity, 

irritation and corrosion to skin and eyes, 

and lung effects based on analogy to 

similar quaternary compounds. As 

described in the PMN, significant 

inhalation exposure is unlikely. 

Therefore, EPA has not determined that 

the proposed manufacturing, 

processing, or use of the substance may 

present an unreasonable risk. EPA has 

determined, however, that other uses of 

the substance other than as described in 

the PMN may result in significant 

human exposure. Based on this 

information, the PMN substance meets 

the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that a prenatal 

developmental toxicity study by the oral 

route in rats or rabbits (OPPTS 870.3700 

test guideline) and a repeated dose 28- 

day oral toxicity study in rats (OPPTS 

870.3050 test guideline) would help 

characterize the human health effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10055. 

PMN Number P–03–47 

Chemical name: 

Benzenemethanaminium, N-(3- 

aminopropyl)-N,N-dimethyl-, N-soya 

acyl derivs., chlorides. 

CAS number: 90194–13–1. 

Basis for action: The PMN states that the 

generic (non-confidential) use of 

substance will be as an oilfield 

corrosion inhibitor. EPA has identified 

health concerns for developmental 

toxicity, neurotoxicity, lung effects, 

irritation to the lungs and mucous 

membranes, and severe eye irritation 

based on analogy to similar quaternary 

compounds. As described in the PMN, 

significant inhalation exposure is 

unlikely. Therefore, EPA has not 

determined that the proposed 

manufacturing, processing, or use of the 

substance may present an unreasonable 

risk. EPA has determined, however, that 

other uses of the substance other than as 

described in the PMN may result in 

significant human exposure. Based on 

this information, the PMN substance 

meets the concern criteria at 

§ 721.170(b)(3)(ii). 

Recommended testing: EPA has 

determined that a prenatal 

developmental toxicity study by the oral 

route in rats or rabbits (OPPTS 870.3700 

test guideline) and a repeated dose 28- 

day oral toxicity study in rats (OPPTS 

870.3050 test guideline) would help 

characterize the human health effects of 

the PMN substance. 

CFR citation: 40 CFR 721.10056. 

IV. Objectives and Rationale for this 

Rule 

A. Rationale 

During review of the PMNs submitted 

for the chemical substances that are 

subject to these SNURs, EPA concluded 

that for 13 of the 65 chemical 

substances, regulation was warranted 

under section 5(e) of TSCA, pending the 

development of information sufficient to 

make reasoned evaluations of the health 

or environmental effects of the chemical 

substances. The basis for such findings 

is outlined in Unit III. Based on these 

findings, TSCA section 5(e) consent 

orders requiring the use of appropriate 

exposure controls were negotiated with 

the PMN submitters; the SNUR 

provisions for these chemical 

substances listed in this document are 

consistent with the provisions of the 

TSCA section 5(e) consent orders. 

In the other 52 cases for which the 

proposed uses are not regulated under a 

TSCA section 5(e) consent order, EPA 

determined that one or more of the 

criteria of concern established at 40 CFR 

721.170 were met, as discussed in Unit 

III. 

B. Objectives 

EPA is issuing these SNURs for 

specific chemical substances which 

have undergone premanufacture review 

because the Agency wants to achieve 

the following objectives with regard to 

the significant new uses designated in 

this rule: 

1. EPA will receive notice of any 

person’s intent to manufacture, import, 

or process a listed chemical substance 

for the described significant new use 

before that activity begins. 

2. EPA will have an opportunity to 

review and evaluate data submitted in a 

SNUN before the notice submitter 

begins manufacturing, importing, or 

processing a listed chemical substance 

for the described significant new use. 

3. EPA will be able to regulate 

prospective manufacturers, importers, 

or processors of a listed chemical 

substance before the described 

significant new use of the chemical 

substance occurs, provided that 

regulation is warranted pursuant to 

TSCA sections 5(e), 5(f), 6 or 7. 

4. EPA will ensure that all 

manufacturers, importers, and 

processors of the same chemical 

substance that is subject to a TSCA 

section 5(e) consent order are subject to 

similar requirements. 

Issuance of a SNUR for a chemical 

substance does not signify that the 

chemical substance is listed on the 

TSCA Inventory. Manufacturers, 

importers, and processors are 

responsible for ensuring that a new 

chemical substance subject to a final 

SNUR is listed on the TSCA Inventory. 

V. Direct Final Procedures 

EPA is issuing these SNURs as a 

direct final rule, as described in 40 CFR 

721.160(c)(3) and 721.170(d)(4). In 

accordance with 40 CFR 

721.160(c)(3)(ii) and 721.170(d)(4)(i), 

this rule will be effective May 29, 2007, 

unless EPA receives a written notice by 

April 30, 2007 of adverse or critical 

comments, or notice of intent to submit 

adverse or critical comments, on EPA’s 

action. If EPA receives such a notice, 

EPA will publish a document to 

withdraw the direct final SNUR for the 

specific chemical substance to which 

the adverse or critical comments apply. 

EPA will then propose a SNUR for the 

specific chemical substance providing a 

30-day comment period. 

This action establishes SNURs for a 

number of chemical substances. Any 

person who submits adverse or critical 

comments or notice of intent to submit 

adverse or critical comments, must 

identify the chemical substance and the 

new use to which it applies. EPA will 

not withdraw a SNUR for a chemical 

substance not identified in a notice. 

VI. Test Data and Other Information 

EPA recognizes that TSCA section 5 

does not require developing any 

particular test data before submission of 

a SNUN. Persons are required only to 

submit test data in their possession or 

control and to describe any other data 

known to or reasonably ascertainable by 

them. However, upon review of PMNs 

and SNUNs, the Agency has the 

authority to require appropriate testing. 

In cases where EPA issued a TSCA 

section 5(e) consent order that requires 

or recommends certain testing, Unit III. 

lists those tests. Unit III. also lists 

recommended testing for non-5(e) 

SNURs. Descriptions of recommended 

tests are provided for informational 

purposes. EPA strongly encourages 

persons, before performing any testing, 

to consult with the Agency pertaining to 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14695 

protocol selection. Many test guidelines 

are now available on the Internet at 

http://www.epa.gov/opptsfrs/home/ 

guidelin.htm. 

In the TSCA section 5(e) consent 

orders for several of the chemical 

substances regulated under this rule, 

EPA has established production limits 

in view of the lack of data on the 

potential health and environmental 

risks that may be posed by the 

significant new uses or increased 

exposure to the chemical substances. 

These production limits cannot be 

exceeded unless the PMN submitter first 

submits the results of toxicity tests that 

would permit a reasoned evaluation of 

the potential risks posed by these 

chemical substances. Under recent 

consent orders, each PMN submitter is 

required to submit each study at least 14 

weeks (earlier consent orders required 

submissions at least 12 weeks) before 

reaching the specified production limit. 

Listings of the tests specified in the 

TSCA section 5(e) consent orders are 

included in Unit III. The SNURs contain 

the same production volume limits as 

the consent orders. Exceeding these 

production limits is defined as a 

significant new use. Persons who intend 

to exceed the production limit must 

notify the Agency by submitting a 

SNUN at least 90 days in advance. 

The recommended tests may not be 

the only means of addressing the 

potential risks of the chemical 

substance. However, SNUNs submitted 

for significant new uses without any test 

data may increase the likelihood that 

EPA will take action under TSCA 

section 5(e), particularly if satisfactory 

test results have not been obtained from 

a prior submitter. EPA recommends that 

potential SNUN submitters contact EPA 

early enough so that they will be able 

to conduct the appropriate tests. 

SNUN submitters should be aware 

that EPA will be better able to evaluate 

SNUNs which provide detailed 

information on the following: 

1. Human exposure and 

environmental release that may result 

from the significant new use of the 

chemical substances. 

2. Potential benefits of the chemical 

substances. 

3. Information on risks posed by the 

chemical substances compared to risks 

posed by potential substitutes. 

VII. Procedural Determinations 

EPA is establishing through this rule 

certain significant new uses which have 

been claimed as CBI subject to Agency 

confidentiality regulations at 40 CFR 

part 2. EPA is required to keep this 

information confidential to protect the 

CBI of the original PMN submitter. EPA 

promulgated a procedure to deal with 

the situation where a specific significant 

new use is CBI. This procedure appears 

in 40 CFR 721.1725(b)(1) and is similar 

to that in § 721.11 for situations where 

the chemical identity of the chemical 

substance subject to a SNUR is CBI. This 

procedure is cross-referenced in each of 

the SNURs that include specific 

significant new uses that are CBI. 

A manufacturer or importer may 

request EPA to determine whether a 

proposed use would be a significant 

new use under this rule. Under the 

procedure in § 721.1725(b)(1), a 

manufacturer or importer must show 

that it has a bona fide intent to 

manufacture or import the chemical 

substance and must identify the specific 

use for which it intends to manufacture 

or import the chemical substance. If 

EPA concludes that the person has 

shown a bona fide intent to manufacture 

or import the chemical substance, EPA 

will tell the person whether the use 

identified in the bona fide submission 

would be a significant new use under 

the rule. Since most of the chemical 

identities of the chemical substances 

subject to these SNURs are also CBI, 

manufacturers and processors can 

combine the bona fide submission 

under the procedure in § 721.1725(b)(1) 

with that under § 721.11 into a single 

step. 

If a manufacturer or importer is told 

that the production volume identified in 

the bona fide submission would not be 

a significant new use, i.e., it is below the 

level that would be a significant new 

use, that person can manufacture or 

import the chemical substance as long 

as the aggregate amount does not exceed 

that identified in the bona fide 

submission to EPA. If the person later 

intends to exceed that volume, a new 

bona fide submission would be 

necessary to determine whether that 

higher volume would be a significant 

new use. EPA is considering whether to 

adopt a special procedure for use when 

CBI production volume is designated as 

a significant new use. Under such a 

procedure, a person showing a bona fide 

intent to manufacture or import the 

chemical substance, under the 

procedure described in § 721.11, would 

automatically be informed of the 

production volume that would be a 

significant new use. Thus, the person 

would not have to make multiple bona 

fide submissions to EPA for the same 

chemical substance to remain in 

compliance with the SNUR, as could be 

the case under the procedures in 

§ 721.1725(b)(1). 

VIII. Applicability of Rule to Uses 

Occurring Before Effective Date of the 

Final Rule 

To establish a significant ‘‘new’’ use, 

EPA must determine that the use is not 

ongoing. The chemical substances 

subject to this rule have recently 

undergone premanufacture review. 

TSCA section 5(e) consent orders have 

been issued for 13 chemical substances 

and notice submitters are prohibited by 

the TSCA section 5(e) consent orders 

from undertaking activities which EPA 

is designating as significant new uses. In 

cases where EPA has not received a 

notice of commencement (NOC) and the 

chemical substance has not been added 

to the TSCA Inventory, no other person 

may commence such activities without 

first submitting a PMN. For chemical 

substances for which an NOC has not 

been submitted at this time, EPA has 

concluded that the uses are not ongoing. 

However, EPA recognizes in cases when 

chemical substances identified in this 

SNUR are added to the TSCA Inventory 

prior to the effective date of the rule, the 

chemical substances may be 

manufactured, imported, or processed 

by other persons for a significant new 

use as defined in this rule before the 

effective date of the rule. However, 35 

of the 65 chemical substances contained 

in this rule have CBI chemical 

identities, and since EPA has received a 

limited number of post-PMN bona fide 

submissions (per 40 CFR 720.25 and 

721.11), the Agency believes that it is 

highly unlikely that any of the 

significant new uses described in the 

following regulatory text are ongoing. 

EPA solicits comments on whether any 

of the uses described as significant new 

uses are ongoing. 

As discussed in the Federal Register 

of April 24, 1990 (55 FR 17376), EPA 

has decided that the intent of section 

5(a)(1)(B) of TSCA is best served by 

designating a use as a significant new 

use as of the date of publication of this 

direct final rule rather than as of the 

effective date of the rule. If uses begun 

after publication were considered 

ongoing rather than new, it would be 

difficult for EPA to establish SNUR 

notice requirements because a person 

could defeat the SNUR by initiating the 

significant new use before the rule 

became final, and then argue that the 

use was ongoing as of the effective date 

of the final rule. Thus, persons who 

begin commercial manufacture, import, 

or processing of the chemical substances 

regulated through this SNUR will have 

to cease any such activity before the 

effective date of this rule. To resume 

their activities, these persons would 

have to comply with all applicable 


cprice-sewell on PROD1PC61 with RULES
14696 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

SNUR notice requirements and wait 

until the notice review period, 

including all extensions, expires. EPA 

has promulgated provisions to allow 

persons to comply with this SNUR 

before the effective date. If a person 

were to meet the conditions of advance 

compliance under § 721.45(h), the 

person would be considered to have met 

the requirements of the final SNUR for 

those activities. 

IX. SNUN Submissions 

EPA recommends that submitters 

consult with the Agency prior to 

submitting a SNUN to discuss what data 

may be useful in evaluating a significant 

new use. Discussions with the Agency 

prior to submission can afford 

submitters ample time to conduct any 

tests that might be helpful in evaluating 

risks posed by the substance. According 

to 40 CFR 721.1(c), persons submitting 

a SNUN must comply with the same 

notice requirements and EPA regulatory 

procedures as persons submitting a 

PMN, including submission of test data 

on health and environmental effects as 

described in 40 CFR 720.50. 

SNUNs must be mailed to the 

Environmental Protection Agency, 

OPPT Document Control Office 

(7407M), 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001. 

Information must be submitted in the 

form and manner set forth in EPA Form 

No. 7710–25. This form is available 

from the Environmental Assistance 

Division (7408M), 1200 Pennsylvania 

Ave., NW., Washington, DC 20460–0001 

(see 40 CFR 721.25 and 720.40). Forms 

and information are also available 

electronically at http://www.epa.gov/ 

opptintr/newchems/pubs/ 

pmnforms.htm. 

X. Notification on Substances for Which 

Significant New Use Rules are Not 

Being Issued 

As required in 40 CFR 721.160(a)(2), 

EPA is providing notification on the 

following two chemical substances that 

are subject to final TSCA section 5(e) 

consent orders but for which EPA has 

decided not to issue significant new use 

rules at this time. EPA is not publishing 

SNURs for PMNs P–02–193 and P–03–

394 because they are subject to 

exposure-based consent orders. EPA’s 

exposure-based policies for new 

chemical substances are based on TSCA 

section 5(e)(1)(A)(ii)(II) and are 

described on the New Chemicals 

website at http://www.epa.gov/oppt/ 

newchems/pubs/expbased.htm. 

Exposure-based consent orders are 

based on two findings: 1) Insufficient 

information available on the health and 

environmental effects of the PMN 

substance, and 2) expected substantial 

production volume and significant or 

substantial human exposure and/or 

release to the environment. Exposurebased consent orders prohibit the 

submitter from exceeding a specific, 

aggregate production or import volume 

unless the submitter has conducted the 

fate, aquatic toxicity, and/or health 

effects testing specified in the order and 

submitted the results to EPA. The 

production or import volume limit is 

usually set so that it will occur within 

a few years. Therefore, instead of 

publishing and often revoking exposurebased SNURs within a short timespan, 

EPA generally defers publication of 

SNURs on substances subject to 

exposure-based consent orders until the 

test data are received. In many cases, 

data received through an exposurebased consent order confirm the 

Agency’s prediction of low or no risk, so 

no further regulatory action is 

warranted. 

XI. Economic Analysis 

EPA has evaluated the potential costs 

of establishing SNUN requirements for 

potential manufacturers, importers, and 

processors of the chemical substances 

subject to this rule. EPA’s complete 

economic analysis is available in the 

public docket. 

XII. Statutory and Executive Order 

Reviews 

1. Executive Order 12866: Regulatory 

Planning and Review 

Under Executive Order 12866, 

entitled Regulatory Planning and 

Review (58 FR 51735, October 4, 1993), 

the Office of Management and Budget 

(OMB) has determined that a proposed 

or final SNUR is not a ‘‘significant 

regulatory action’’ subject to review by 

OMB, because it does not meet the 

criteria in section 3(f) of the Executive 

order. 

2. Paperwork Reduction Act 

According to the Paperwork 

Reduction Act (PRA), 44 U.S.C. 3501 et 

seq., an Agency may not conduct or 

sponsor, and a person is not required to 

respond to a collection of information 

that requires OMB approval under the 

PRA, unless it has been approved by 

OMB and displays a currently valid 

OMB control number. The OMB control 

numbers for EPA’s regulations in title 40 

of the CFR, after appearing in the 

Federal Register, are listed in 40 CFR 

part 9, and included on the related 

collection instrument or form, if 

applicable. 

The information collection 

requirements related to this action have 

already been approved by OMB 

pursuant to the PRA under OMB control 

number 2070–0012 (EPA ICR No. 574). 

This action does not impose any burden 

requiring additional OMB approval. If 

an entity were to submit a SNUN to the 

Agency, the annual burden is estimated 

to average between 30 and 170 hours 

per response. This burden estimate 

includes the time needed to review 

instructions, search existing data 

sources, gather and maintain the data 

needed, and complete, review, and 

submit the required SNUN. 

Send any comments about the 

accuracy of the burden estimate, and 

any suggested methods for minimizing 

respondent burden, including through 

the use of automated collection 

techniques, to the Director, Collection 

Strategies Division, Office of 

Environmental Information (2822T), 

Environmental Protection Agency, 1200 

Pennsylvania Ave., NW., Washington, 

DC 20460–0001. Please remember to 

include the OMB control number in any 

correspondence, but do not submit any 

completed forms to this address. 

3. Regulatory Flexibility Act 

Pursuant to section 605(b) of the 

Regulatory Flexibility Act (RFA) (5 

U.S.C. 601 et seq.), the Agency hereby 

certifies that promulgation of this SNUR 

will not have a significant adverse 

economic impact on a substantial 

number of small entities. The rationale 

supporting this conclusion is as follows. 

A SNUR applies to any person 

(including small or large entities) who 

intends to engage in any activity 

described in the rule as a ‘‘significant 

new use.’’ By definition of the word 

‘‘new,’’ and based on all information 

currently available to EPA, it appears 

that no small or large entities presently 

engage in such activity. Since a SNUR 

only requires that any person who 

intends to engage in such activity in the 

future must first notify EPA by 

submitting a SNUN, no economic 

impact will even occur until someone 

decides to engage in those activities. 

Although some small entities may 

decide to conduct such activities in the 

future, EPA cannot presently determine 

how many, if any, there may be. 

However, EPA’s experience to date is 

that, in response to the promulgation of 

over 1,000 SNURs, the Agency receives 

on average only 10 notices per year. Of 

those SNUNs submitted, none appear to 

be from small entities in response to any 

SNUR. In addition, the estimated 

reporting cost for submission of a SNUN 

(see Unit IX.), is minimal regardless of 

the size of the firm. Therefore, EPA 

believes that the potential economic 

impact of complying with this SNUR is 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14697 

not expected to be significant or 

adversely impact a substantial number 

of small entities. In a SNUR that 

published on June 2, 1997 (62 FR 29684) 

(FRL–5597–1), the Agency presented it’s 

general determination that proposed 

and final SNURs are not expected to 

have a significant economic impact on 

a substantial number of small entities, 

which was provided to the Chief 

Counsel for Advocacy of the Small 

Business Administration. 

4. Unfunded Mandates Reform Act 

Based on EPA’s experience with 

proposing and finalizing SNURs, State, 

local, and Tribal governments have not 

been impacted by these rulemakings, 

and EPA does not have any reason to 

believe that any State, local, or Tribal 

government will be impacted by this 

rulemaking. As such, EPA has 

determined that this regulatory action 

does not impose any enforceable duty, 

contain any unfunded mandate, or 

otherwise have any affect on small 

governments subject to the requirements 

of sections 202, 203, 204, or 205 of the 

Unfunded Mandates Reform Act of 1995 

(UMRA) (Public Law 104–4). 

5. Executive Order 13132: Federalism 

This action will not have a substantial 

direct effect on States, on the 

relationship between the national 

government and the States, or on the 

distribution of power and 

responsibilities among the various 

levels of government, as specified in 

Executive Order 13132, entitled 

Federalism (64 FR 43255, August 10, 

1999). 

6. Executive Order 13175: Consultation 

and Coordination with Indian Tribal 

Governments 

This rule does not have Tribal 

implications because it is not expected 

to have substantial direct effects on 

Indian Tribes. This does not 

significantly or uniquely affect the 

communities of Indian Tribal 

governments, nor does it involve or 

impose any requirements that affect 

Indian Tribes. Accordingly, the 

requirements of Executive Order 13175, 

entitled Consultation and Coordination 

with Indian Tribal Governments (65 FR 

67249, November 6, 2000), do not apply 

to this rule. 

7. Executive Order 13045: Protection of 

Children from Environmental Health 

Risks and Safety Risks 

This action is not subject to Executive 

Order 13045, entitled Protection of 

Children from Environmental Health 

Risks and Safety Risks (62 FR 19885, 

April 23, 1997), because this is not an 

economically significant regulatory 

action as defined by Executive Order 

12866, and this action does not address 

environmental health or safety risks 

disproportionately affecting children. 

8. Executive Order 13211: Actions that 

Significantly Affect Energy Supply, 

Distribution, or Use 

This rule is not subject to Executive 

Order 13211, entitled Actions 

Concerning Regulations That 

Significantly Affect Energy Supply, 

Distribution, or Use (66 FR 28355, May 

22, 2001), because this action is not 

expected to affect energy supply, 

distribution, or use. 

9. National Technology Transfer 

Advancement Act 

In addition, since this action does not 

involve any technical standards, section 

12(d) of the National Technology 

Transfer and Advancement Act of 1995 

(NTTAA), Public Law 104–113, section 

12(d) (15 U.S.C. 272 note), does not 

apply to this action. 

10. Executive Order 12898: Federal 

Actions to Address Environmental 

Justice in Minority Populations and 

Low-Income Populations 

This action does not entail special 

considerations of environmental justice 

related issues as delineated by 

Executive Order 12898, entitled Federal 

Actions to Address Environmental 

Justice in Minority Populations and 

Low-Income Populations (59 FR 7629, 

February 16, 1994). 

11. Executive Order 12630: 

Governmental Actions and Interference 

with Constitutionally Protected Property 

Rights (Takings) 

EPA has complied with Executive 

Order 12630, entitled Governmental 

Actions and Interference with 

Constitutionally Protected Property 

Rights (53 FR 8859, March 15, 1988), by 

examining the takings implications of 

this rule in accordance with the 

‘‘Attorney General’s Supplemental 

Guidelines for the Evaluation of Risk 

and Avoidance of Unanticipated 

Takings’’ issued under the Executive 

order. 

12. Executive Order 12988: Civil Justice 

Reform 

In issuing this rule, EPA has taken the 

necessary steps to eliminate drafting 

errors and ambiguity, minimize 

potential litigation, and provide a clear 

legal standard for affected conduct, as 

required by section 3 of Executive Order 

12988, entitled Civil Justice Reform (61 

FR 4729, February 7, 1996). 

13. Congressional Review Act 

The Congressional Review Act, 5 

U.S.C. 801 et seq., generally provides 

that before a final rule may take effect, 

the Agency promulgating the final rule 

must submit a final rule report to each 

House of the Congress and to the 

Comptroller General of the United 

States. EPA will submit a report 

containing this final rule and other 

required information to the U.S. Senate, 

the U.S. House of Representatives, and 

the Comptroller General of the United 

States prior to publication of this final 

rule in the Federal Register. This final 

rule is not a ‘‘major rule’’ as defined by 

5 U.S.C. 804(2). 

List of Subjects in 40 CFR Part 721 

Environmental protection, Chemicals, 

Hazardous substances, Reporting and 

recordkeeping requirements. 

Dated: March 22, 2007. 

Charles M. Auer, 

Director, Office of Pollution Prevention and 

Toxics. 

■ Therefore, 40 CFR part 721 is 

amended as follows: 

PART 721—[AMENDED] 

■ 1. The authority citation for part 721 

continues to read as follows: 

Authority: 15 U.S.C. 2604, 2607, and 

2625(c). 

■ 2. By adding new § 721.10002 to 

subpart E to read as follows: 

§ 721.10002 2-Thiazolidinone. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

2-thiazolidinone (PMN P–97–415; CAS 

No. 2682–49–7) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(1), (a)(3), (a)(4), (a)(6)(i), (b), and (c). 

The following National Institute for 

Occupational Safety and Health 

(NIOSH)-approved respirators with an 

assigned protection factor (APF) of 10–

25 meet the minimum requirements for 

§ 721.63(a)(4): Air-purifying, tight-fitting 

respirator (either half- or full-face) 

equipped with N100 (if aerosols absent), 

R100, or P100 filters; powered airpurifying respirator equipped with a 

loose-fitting hood or helmet and High 

Efficiency Particulate Air (HEPA) filters; 

powered air-purifying respirator 

equipped with a tight-fitting facepiece 

(either half- or full-face) and HEPA 

filters; and supplied-air respirator 

operated in pressure demand or 


cprice-sewell on PROD1PC61 with RULES
14698 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

continuous flow mode and equipped 

with a hood or helmet or tight-fitting 

facepiece (either half- or full-face). As 

an alternative to the respiratory 

requirements listed here, a 

manufacturer, importer, or processor 

may choose to follow the new chemical 

exposure limit (NCEL) provisions listed 

in the TSCA section 5(e) consent order 

for this substance. The NCEL is 0.7 mg/ 

m3 as an 8-hour time-weighted average. 

Persons who wish to pursue NCELs as 

an alternative to the § 721.63 respirator 

requirements may request to do so 

under 40 CFR 721.30. Persons whose 

§ 721.30 requests to use the NCELs 

approach are approved by EPA will 

receive NCELs provisions comparable to 

those contained in the corresponding 

section 5(e) consent order. 

(ii) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

1.0 percent), (f), (g)(1)(iii), (g)(1)(iv), 

(g)(1)(vi), (g)(1)(ix), (g)(2)(i), (g)(2)(ii), 

(g)(2)(iii), (g)(2)(iv) (use respiratory 

protection or maintain workplace 

airborne concentrations at or below an 

8-hour time-weighted average of 0.7 mg/ 

m3), (g)(2)(v), (g)(3)(ii), (g)(4)(i), (g)(4)(ii), 

(g)(4)(iii), and (g)(5). The following 

statement shall appear on each label as 

specified in § 721.72(b) and the Material 

Safety Data Sheet (MSDS) as specified 

in § 721.72(c). The substance may cause 

severe eye irritation. The substance may 

cause internal organ effects (blood, liver, 

and kidney). The substance may cause 

developmental/maternal effects. When 

handling this substance as a powder, 

use respiratory protection. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (g), (p) (300,000 

kilograms), (v)(1), (w)(1), and (x)(1). 

(iv) Disposal. Requirements as 

specified in § 721.85 (a)(1), (a)(2), (a)(3), 

(b)(1), (b)(2), (b)(3), (c)(1), (c)(2), and 

(c)(3). 

(v) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (e), (f), (g), (h), (i), (j), and 

(k) are applicable to manufacturers, 

importers, and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 3. By adding new § 721.10003 to 

subpart E to read as follows: 

§ 721.10003 Manganese heterocyclic 

tetraamine complex (generic). 

(a) Chemical substances and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as manganese heterocyclic 

tetraamine complex (PMNs P–98–625/ 

626/627/628/629 and P–00–614/617) are 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(s) (10,000 

kilograms per chemical substance). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 4. By adding new § 721.10004 to 

subpart E to read as follows: 

§ 721.10004 2-Butenoic acid, 4,4′- 

[(dibutylstannylene)bis(oxy)]bis[4-oxo-, 

(2Z,2′Z)-, di-C8-10-isoalkyl esters, C9-rich. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

2-butenoic acid, 4,4′- 

[(dibutylstannylene)bis(oxy)]bis[4-oxo-, 

(2Z,2′Z)-, di-C8-10-isoalkyl esters, C9-rich 

(PMN P–98–1181; CAS No. 247041–56–

1) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(1), (a)(2)(i), and (a)(3). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (v)(2), (w)(2), 

(x)(2), and (y)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (e), and (i) are applicable 

to manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 5. By adding new § 721.10005 to 

subpart E to read as follows: 

§ 721.10005 2-Butenoic acid, 4,4′- 

[(dibutylstannylene)bis(oxy)]bis [4-oxo-, 

(2Z,2′Z)-, di-C9-11-isoalkyl esters, C10-rich. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

2-butenoic acid, 4 ,4′- 

[(dibutylstannylene)bis(oxy)]bis [4-oxo-, 

(2Z,2′Z)-, di-C9-11-isoalkyl esters, C10- 

rich (PMN P–98–1182) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(1), (a)(2)(i), and (a)(3). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (v)(2), (w)(2), 

(x)(2), and (y)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (e), and (i) are applicable 

to manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 6. By adding new § 721.10006 to 

subpart E to read as follows: 

§ 721.10006 Mixed metal oxide (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as mixed metal oxide (PMN 

P–99–511) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(s) (60,000 

kilograms). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 7. By adding new § 721.10007 to 

subpart E to read as follows: 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14699 

§ 721.10007 Alcohols, C12-14- secondary, 

ethoxylated propoxylated. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

alcohols, C12-14- secondary, ethoxylated 

propoxylated (PMN P–00–11; CAS No. 

103331–86–8) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N = 50). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 8. By adding new § 721.10008 to 

subpart E to read as follows: 

§ 721.10008 Manganese strontium oxide 

(MnSrO3). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

manganese strontium oxide (MnSrO3) 

(PMN P–00–1121; CAS No. 12163–45–0) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 9. By adding new § 721.10009 to 

subpart E to read as follows: 

§ 721.10009 Manganese yttrium oxide 

(MnYO3). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

manganese yttrium oxide (MnYO3) 

(PMN P–00–1122; CAS No. 12032–75–6) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 10. By adding new § 721.10010 to 

subpart E to read as follows: 

§ 721.10010 Barium manganese oxide 

(BaMnO3). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

barium manganese oxide (BaMnO3) 

(PMN P–00–1123; CAS No. 12230–80–7) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 11. By adding new § 721.10011 to 

subpart E to read as follows: 

§ 721.10011 Barium calcium manganese 

strontium oxide. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

barium calcium manganese strontium 

oxide (PMN P–00–1124; CAS No. 

359427–90–0) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 


cprice-sewell on PROD1PC61 with RULES
14700 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 12. By adding new § 721.10012 to 

subpart E to read as follows: 

§ 721.10012 Manganate (MnO2

1-), calcium 

(2:1). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

manganate (MnO2

1-), calcium (2:1) 

(PMN P–00–1125; CAS No. 12049–47–7) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 13. By adding new § 721.10013 to 

subpart E to read as follows: 

§ 721.10013 Manganese yttrium oxide 

(Mn2YO5). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

manganese yttrium oxide (Mn2YO5) 

(PMN P–00–1126; CAS No. 12438–71–0) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set at 

0.1 percent), (f), (g)(1)(i), (g)(1)(ii), 

(g)(1)(iii), (g)(1)(vii), (g)(1)(viii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iii), (g)(2)(v), (g)(3)(ii), 

(g)(4)(i), and (g)(5). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (k) (manufacture, 

processing, or use of the PMN substance 

if the particle size is less than 10 

microns) and (q). 

(iii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (f), (g), (h), (i), and (k) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 14. By adding new § 721.10014 to 

subpart E to read as follows: 

§ 721.10014 Halogenated naphthalic 

anhydride (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as halogenated naphthalic 

anhydride (PMN P–01–109) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 15. By adding new § 721.10015 to 

subpart E to read as follows: 

§ 721.10015 Halogenated benzimidazole 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as halogenated 

benzimidazole (PMN P–01–110) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 16. By adding new § 721.10016 to 

subpart E to read as follows: 

§ 721.10016 

Dibenzimidazothianaphthalene (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as 

dibenzimidazothianaphthalene (PMN 

P–01–111) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 17. By adding new § 721.10017 to 

subpart E to read as follows: 

§ 721.10017 Amine terminated bisphenol A 

diglycidyl ether polymer (generic). 

(a) Chemical substances and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as amine terminated 

bisphenol A diglycidyl ether polymer 

(PMNs P–01–257/258/259 and P–01–

261) are subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14701 

(i) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 18. By adding new § 721.10018 to 

subpart E to read as follows: 

§ 721.10018 Calcium hydroxide oxide 

silicate (Ca6(OH)2O2(Si2O5)3). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

calcium hydroxide oxide silicate 

(Ca6(OH)2O2(Si2O5)3) (PMN P–01–442; 

CAS No. 13169–90–9) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (f), (j) (use other 

than as filler to reinforce resins, additive 

for resins, and filter medium), (v)(1), 

and (x)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 19. By adding new § 721.10019 to 

subpart E to read as follows: 

§ 721.10019 Benzoic acid, 2-chloro-5-nitro- 

, 1,1-dimethyl-2-oxo-2-(2-propenyloxy) ethyl 

ester. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

benzoic acid, 2-chloro-5-nitro-, 1,1- 

dimethyl-2-oxo-2-(2-propenyloxy) ethyl 

ester (PMN P–01–563; CAS No. 174489–

76–0) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 20. By adding new § 721.10020 to 

subpart E to read as follows: 

§ 721.10020 Benzoic acid, 5-amino-2- 

chloro-, 1,1-dimethyl-2-oxo-2-(2- 

propenyloxy) ethyl ester. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

benzoic acid, 5-amino-2-chloro-, 1,1- 

dimethyl-2-oxo-2-(2-propenyloxy) ethyl 

ester (PMN P–01–564; CAS No. 174489–

43–1) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 21. By adding new § 721.10021 to 

subpart E to read as follows: 

§ 721.10021 Magnesium potassium 

titanium oxide. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

magnesium potassium titanium oxide 

(PMN P–01–764; CAS No. 39290–90–9) 

is subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(4), (a)(6)(i), (b) (concentration set at 

0.1 percent), and (c). The following 

National Institute for Occupational 

Safety and Health (NIOSH)-approved 

respirators with an assigned protection 

factor (APF) of 10–25 meet the 

minimum requirements for 

§ 721.63(a)(4): Air-purifying, tight-fitting 

respirator equipped with N100 (if 

aerosols absent), R100, or P100 filters 

(either half- or full-face); powered airpurifying respirator equipped with a 

loose-fitting hood or helmet and High 

Efficiency Particulate Air (HEPA) filters; 

powered air-purifying respirator 

equipped with a tight-fitting facepiece 

(either half- or full-face) and HEPA 

filters; and supplied-air respirator 

operated in pressure demand or 

continuous flow mode and equipped 

with a hood or helmet or tight-fitting 

facepiece (either half- or full-face). As 

an alternative to the respiratory 

requirements listed here, a 

manufacturer, importer, or processor 

may choose to follow the new chemical 

exposure limit (NCEL) provisions listed 

in the TSCA section 5(e) consent order 

for this substance. The NCEL is 5 mg/ 

m3 as an 8-hour time-weighted average. 

Persons who wish to pursue NCELs as 

an alternative to the § 721.63 respirator 

requirements may request to do so 

under 40 CFR 721.30. Persons whose 

§ 721.30 requests to use the NCELs 

approach are approved by EPA will 

receive NCELs provisions comparable to 

those contained in the corresponding 

section 5(e) consent order. 

(ii) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set 0.1 

percent), (f), (g)(1)(ii), (g)(2)(ii), (g)(2)(iv) 

(use respiratory protection or maintain 

workplace airborne concentrations at or 

below an 8-hour time-weighted average 

of 5 mg/m3) and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (f), (g), (h), and (i) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 22. By adding new § 721.10022 to 

subpart E to read as follows: 


cprice-sewell on PROD1PC61 with RULES
14702 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

§ 721.10022 Benzenamine, N-phenyl-, ar′- 

(C9-rich C8-10-branched alkyl) derivs. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

benzenamine, N-phenyl-, ar′-(C9-rich 

C8-10-branched alkyl) derivs (PMN P–

01–769; CAS No. 333955–69–4) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j) (antioxidant for 

lubricating oils). 

(ii) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of these substances. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 23. By adding new § 721.10023 to 

subpart E to read as follows: 

§ 721.10023 Benzenamine, N-phenyl-, ar 

ar′-(C9-rich C8-10-branched alkyl) derivs. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

benzenamine, N-phenyl-, ar,ar′-(C9-rich 

C8-10-branched alkyl) derivs (PMN P–

01–770; CAS No. 333955–70–7) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j) (antioxidant for 

lubricating oils). 

(ii) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of these substances. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 24. By adding new § 721.10024 to 

subpart E to read as follows: 

§ 721.10024 10H-Phenothiazine, ar-(C9-rich 

C8-10-branched alkyl) derivs. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

10H-phenothiazine, ar-(C9-rich C8-10- 

branched alkyl) derivs (PMN P–01–771; 

CAS No. 333955–79–6) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j) (antioxidant for 

lubricating oils). 

(ii) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of these substances. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 25. By adding new § 721.10025 to 

subpart E to read as follows: 

§ 721.10025 10H-Phenothiazine, ar, ar′-(C9- 

rich C8-10-branched alkyl) derivs. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

as 10H-phenothiazine, ar, ar′-(C9-rich 

C8-10-branched alkyl) derivs (PMN P–

01–772; CAS No. 333955–80–9) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j) (antioxidant for 

lubricating oils). 

(ii) Release to water. Requirements as 

specified in § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of these substances. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 26. By adding new § 721.10026 to 

subpart E to read as follows: 

§ 721.10026 Cashew, nutshell liq., 

ethoxylated. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

cashew, nutshell liq., ethoxylated (PMN 

P–01–856; CAS No. 350820–95–0) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(k) (any 

manufacturing, processing, or use of the 

PMN substance with less than 55 moles 

of the ethoxy or with an average 

molecular weight less than 2,700 

daltons). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 27. By adding new § 721.10027 to 

subpart E to read as follows: 

§ 721.10027 Ethoxylated alkylsulfate, 

substituted alkylamine salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as ethoxylated alkylsulfate, 

substituted alkylamine salt (PMN P–01–

862) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14703 

■ 28. By adding new § 721.10028 to 

subpart E to read as follows: 

§ 721.10028 Disubstituted benzene metal 

salts (generic). 

(a) Chemical substances and 

significant new uses subject to reporting. 

(1) The chemical substances identified 

generically as disubstituted benzene 

metal salts (PMNs P–01–901 and P–01–

902) are subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(1) and (a)(3). 

(ii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (e), and (i) are applicable 

to manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 29. By adding new § 721.10029 to 

subpart E to read as follows: 

§ 721.10029 Isocyanate compound, 

modified with methoxysilane (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as isocyanate compound, 

modified with methoxysilane (PMN P–

01–918) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), 

(a)(2)(iv), (a)(3), (a)(4), and (a)(6). The 

following National Institute for 

Occupational Safety and Health 

(NIOSH)-approved respirators meet the 

minimum requirement for 

§ 721.63(a)(4): Air-purifying, tight-fitting 

full-face respirator equipped with N100 

(if oil aerosols absent), R100, or P100 

filters; powered air-purifying respirator 

equipped with a tight-fitting full 

facepiece and High Efficiency 

Particulate Air (HEPA) filters; suppliedair respirator operated in pressure 

demand or continuous flow mode and 

equipped with a tight-fitting full 

facepiece. As an alternative to the 

respiratory requirements listed here, a 

manufacturer, importer, or processor 

may choose to follow the new chemical 

exposure limit (NCEL) provisions listed 

in the TSCA section 5(e) consent order 

for this substance. The NCEL is 0.05 mg/ 

m3 as an 8-hour time-weighted average. 

Persons who wish to pursue NCELs as 

an alternative to the § 721.63 respirator 

requirements may request to do so 

under 40 CFR 721.30. Persons whose 

§ 721.30 requests to use the NCELs 

approach are approved by EPA will 

receive NCELs provisions comparable to 

those contained in the corresponding 

section 5(e) consent order. 

(ii) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set 1.0 

percent), (f), (g)(1)(i), (g)(1)(ii), (g)(2)(i), 

(g)(2)(ii), (g)(2)(iv) (use respiratory 

protection or maintain workplace 

airborne concentrations at or below an 

8-hour time-weighted average of 0.05 

mg/m3), (g)(2)(v), and (g)(5). The 

following statements shall appear on 

each label as specified in § 721.72(b) 

and the Material Safety Data Sheet 

(MSDS) as specified in § 721.72(c): This 

substance may cause skin irritation and 

sensitization. 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (e), (f), (g), (h), and (i) 

are applicable to manufacturers, 

importers, and processors of this 

substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 30. By adding new § 721.10030 to 

subpart E to read as follows: 

§ 721.10030 Pyrimido[5,4-g]pteridine2,4,6,8-tetramine, 4- 

methylbenzenesulfonate, base-hydrolyzed. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

pyrimido[5,4-g]pteridine-2,4,6,8- 

tetramine, 4-methylbenzenesulfonate, 

base-hydrolyzed (PMN P–01–919; CAS 

No. 346709–25–9) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 31. By adding new § 721.10031 to 

subpart E to read as follows: 

§ 721.10031 Lithium potassium titanium 

oxide. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

lithium potassium titanium oxide (PMN 

P–02–214; CAS No. 39318–30–4) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Protection in the workplace. 

Requirements as specified in § 721.63 

(a)(4), (a)(6)(i), (b) (concentration set at 

0.1 percent), and (c). The following 

National Institute for Occupational 

Safety and Health (NIOSH)-approved 

respirators with an APF of 10–25 meet 

the minimum requirements for 

§ 721.63(a)(4): Air-purifying, tight-fitting 

respirator (either half- or full-face) 

equipped with N100 (if aerosols absent), 

R100, or P100 filters; powered airpurifying, respirator equipped with a 

loose-fitting hood or helmet or tightfitting facepiece (either half- or full-face) 

and High Efficiency Particulate Air 

(HEPA) filters; and supplied-air 

respirator operated in pressure demand 

or continuous flow mode and equipped 

with a hood or helmet or tight-fitting 

facepiece (either half- or full-face). As 

an alternative to the respiratory 

requirements listed here, a 

manufacturer, importer, or processor 

may choose to follow the new chemical 

exposure limit (NCEL) provisions listed 

in the TSCA section 5(e) consent order 

for this substance. The NCEL is 5 mg/ 

m3 as an 8-hour time-weighted average. 

Persons who wish to pursue NCELs as 

an alternative to the § 721.63 respirator 

requirements may request to do so 

under 40 CFR 721.30. Persons whose 

§ 721.30 requests to use the NCELs 

approach are approved by EPA will 

receive NCELs provisions comparable to 


cprice-sewell on PROD1PC61 with RULES
14704 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

those contained in the corresponding 

section 5(e) consent order. 

(ii) Hazard communication program. 

Requirements as specified in § 721.72 

(a), (b), (c), (d), (e) (concentration set 0.1 

percent), (f), (g)(1)(ii), (g)(2)(ii), (g)(2)(iv) 

(use respiratory protection or maintain 

workplace airborne concentrations at or 

below an 8-hour time-weighted average 

of 5 mg/m3), and (g)(5). 

(iii) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(q). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (d), (f), (g), (h), and (i) are 

applicable to manufacturers, importers, 

and processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 32. By adding new § 721.10032 to 

subpart E to read as follows: 

§ 721.10032 Acrylic acid, polymer with 

substituted acrylamides (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as acrylic acid, polymer with 

substituted acrylamides (PMN P–02–

269) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(k) (any 

manufacturing, processing, or use of the 

PMN substance with an aerodynamic 

diameter less than 10 microns). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 33. By adding new § 721.10033 to 

subpart E to read as follows: 

§ 721.10033 Zinc, [ethanedioato(2-)-. 

kappa. O1, . kappa. O2]-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

zinc, [ethanedioato(2-)-. kappa. O1, . 

kappa. O2]- (PMN P–02–322; CAS No. 

547–68–2) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 34. By adding new § 721.10034 to 

subpart E to read as follows: 

§ 721.10034 Substituted pyridine coupled 

with diazotized substituted 

nitrobenzonitrile, diazotized substituted 

benzenamine and substituted 

pyridinecarbonitrile (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted pyridine 

coupled with diazotized substituted 

nitrobenzonitrile, diazotized substituted 

benzenamine and substituted 

pyridinecarbonitrile (PMN P–02–359) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 35. By adding new § 721.10035 to 

subpart E to read as follows: 

§ 721.10035 Alkylbenzene sulfonate 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkylbenzene sulfonate 

(PMN–02–382) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(k) (manufacture, 

import, or processing of the chemical 

without 19 percent or more mineral oil 

as a diluent). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 36. By adding new § 721.10036 to 

subpart E to read as follows: 

§ 721.10036 Acetaldehyde based polymer 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as acetaldehyde based 

polymer (PMN P–02–406) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). 

(ii) Release to water. Requirements as 

specified § 721.90 (b)(1) and (c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 37. By adding new § 721.10037 to 

subpart E to read as follows: 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14705 

§ 721.10037 Complex halogenated salt of 

tris(ethylatedaminocarbocyclic)methane 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as complex halogenated salt 

of 

tris(ethylatedaminocarbocyclic)methane 

(PMN P–02–423) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (d) and (e). 

(ii) Release to water. Requirements as 

specified in § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 38. By adding new § 721.10038 to 

subpart E to read as follows: 

§ 721.10038 Trimellitic anhydride, polymer 

with substituted glycol, alkyl phenols and 

ethoxylated nonylphenol (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as trimellitic anhydride, 

polymer with substituted glycol, alkyl 

phenols and ethoxylated nonylphenol 

(PMN P–02–434) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 39. By adding new § 721.10039 to 

subpart E to read as follows: 

§ 721.10039 Diethoxybenzenamine 

derivative, diazotized, coupled with 

aminonaphthalenesulfonic acid derivative, 

ammonium salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as a diethoxybenzenamine 

derivative, diazotized, coupled with 

aminonaphthalenesulfonic acid 

derivative, ammonium salt (PMN P–02–

514) is subject to reporting under this 

section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (f), (v)(2), and 

(x)(2). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 40. By adding new § 721.10040 to 

subpart E to read as follows: 

§ 721.10040 Substituted acridine naphtha 

substituted benzamide (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as a substituted acridine 

naphtha substituted benzamide (PMN 

P–02–522) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(4), (b)(4), and 

(c)(4) (N=2). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply tothis section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 41. By adding new § 721.10041 to 

subpart E to read as follows: 

§ 721.10041 1-Butanone, 2- 

(dimethylamino)-2-[(4- 

methylphenyl)methyl]-1-[4-(4- 

morpholinyl)phenyl]-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-butanone, 2-(dimethylamino)-2-[(4- 

methylphenyl)methyl]-1-[4-(4- 

morpholinyl)phenyl]-(PMN P–02–530; 

CAS No. 119344–86–4) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 42. By adding new § 721.10042 to 

subpart E to read as follows: 

§ 721.10042 2-Propanol, 1-[bis(2- 

hydroxyethyl)amino]-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

2-propanol, 1-[bis(2- 

hydroxyethyl)amino]- (PMN P–02–585; 

CAS No. 6712–98–7) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 43. By adding new § 721.10043 to 

subpart E to read as follows: 


cprice-sewell on PROD1PC61 with RULES
14706 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

§ 721.10043 Dineopentyl-4-substituted 

phthalate (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as dineopentyl-4-substituted 

phthalate (PMN P–02–697) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply tothis section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), (i), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 44. By adding new § 721.10044 to 

subpart E to read as follows: 

§ 721.10044 Metal oxide, modified with 

alkyl and vinyl terminated polysiloxanes 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as metal oxide, modified 

with alkyl and vinyl terminated 

polysiloxanes (PMN P–02–698) is 

subject to reporting under this section 

for the significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (v)(1), (w)(1), and 

(x)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 45. By adding new § 721.10045 to 

subpart E to read as follows: 

§ 721.10045 Diazotized substituted 

heteromonocycle coupled with naphthalene 

sulfonic acid derivative, nickel complex, 

alkaline salt (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as a diazotized substituted 

heteromonocycle coupled with 

naphthalene sulfonic acid derivative, 

nickel complex, alkaline salt (PMN P–

02–737) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80 (f), (v)(2), and 

(x)(2). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 46. By adding new § 721.10046 to 

subpart E to read as follows: 

§ 721.10046 Polyaromatic amine 

phosphate (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as polyaromatic amine 

phosphate (PMN P–02–747) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 47. By adding new § 721.10047 to 

subpart E to read as follows: 

§ 721.10047 Polyphosphoric acids, 

compds. with piperazine. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

a polyphosphoric acids, compds. with 

piperazine (PMN P–02–766; CAS No. 

383905–85–9) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 48. By adding new § 721.10048 to 

subpart E to read as follows: 

§ 721.10048 Substituted anthraquinone 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as substituted anthraquinone 

(PMN P–02–869) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(s) (4,500 

kilograms). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 49. By adding new § 721.10049 to 

subpart E to read as follows: 


cprice-sewell on PROD1PC61 with RULES
Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 14707 

§ 721.10049 Phenol, 4,4′- cyclohexylidene 

bis[2-methyl-. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

a phenol, 4,4′- cyclohexylidene bis[2- 

methyl- (PMN P–02–912; CAS No. 

2362–14–3) is subject to reporting under 

this section for the significant new uses 

described in paragraph (a)(2) of this 

section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 50. By adding new § 721.10050 to 

subpart E to read as follows: 

§ 721.10050 Disubstituted-N′- hydroxybenzenecarboximidamide (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as disubstituted-N′- 

hydroxy-benzenecarboximidamide 

(PMN P–02–929) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(g). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 51. By adding new § 721.10051 to 

subpart E to read as follows: 

§ 721.10051 Spiro naphthoxazine 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as spiro naphthoxazine 

(PMN P–02–961) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(f). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 52. By adding new § 721.10052 to 

subpart E to read as follows: 

§ 721.10052 Aminoalkyl substituted 

alkylphenol (generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as aminoalkyl substituted 

alkylphenol (PMN P–02–1088) is subject 

to reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 53. By adding new § 721.10053 to 

subpart E to read as follows: 

§ 721.10053 Alkyl silane methacrylate 

(generic). 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as alkyl silane methacrylate 

(PMN P–03–41) is subject to reporting 

under this section for the significant 

new uses described in paragraph (a)(2) 

of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 54. By adding new § 721.10054 to 

subpart E to read as follows: 

§ 721.10054 Phenol, polymer with 

formaldehyde, 3-[(2- 

aminocyclohexyl)amino]-2-hydroxypropyl 

ethers. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified 

generically as a phenol, polymer with 

formaldehyde, 3-[(2- 

aminocyclohexyl)amino]-2- 

hydroxypropyl ethers (PMN P–03–43; 

CAS No. 452082–53–0) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Release to water. Requirements as 

specified § 721.90 (a)(1), (b)(1), and 

(c)(1). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (k) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

■ 55. By adding new § 721.10055 to 

subpart E to read as follows: 

§ 721.10055 1-Propanaminium, 3-amino-N- 

(carboxymethyl)-N,N-dimethyl-, N-soya acyl 

derivs., inner salts. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

1-propanaminium, 3-amino-N- 

(carboxymethyl)-N,N-dimethyl-, N-soya 

acyl derivs., inner salts (PMN P–03–46; 

CAS No. 136504–87–5) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 


cprice-sewell on PROD1PC61 with RULES
14708 Federal Register / Vol. 72, No. 60 / Thursday, March 29, 2007 / Rules and Regulations 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

■ 56. By adding new § 721.10056 to 

subpart E to read as follows: 

§ 721.10056 Benzenemethanaminium, N- 

(3-aminopropyl)-N,N-dimethyl-, N-soya acyl 

derivs., chlorides. 

(a) Chemical substance and 

significant new uses subject to reporting. 

(1) The chemical substance identified as 

benzenemethanaminium, N-(3- 

aminopropyl)-N,N-dimethyl-, N-soya 

acyl derivs., chlorides (PMN P–03–47; 

CAS No. 90194–13–1) is subject to 

reporting under this section for the 

significant new uses described in 

paragraph (a)(2) of this section. 

(2) The significant new uses are: 

(i) Industrial, commercial, and 

consumer activities. Requirements as 

specified in § 721.80(j). 

(ii) [Reserved] 

(b) Specific requirements. The 

provisions of subpart A of this part 

apply to this section except as modified 

by this paragraph. 

(1) Recordkeeping. Recordkeeping 

requirements as specified in § 721.125 

(a), (b), (c), and (i) are applicable to 

manufacturers, importers, and 

processors of this substance. 

(2) Limitations or revocation of 

certain notification requirements. The 

provisions of § 721.185 apply to this 

section. 

(3) Determining whether a specific use 

is subject to this section. The provisions 

of § 721.1725(b)(1) apply to this section. 

[FR Doc. E7–5797 Filed 3–28–07; 8:45 am] 

BILLING CODE 6560–50–S 


cprice-sewell on PROD1PC61 with RULES